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1. INTRODUCTION {#tbed13356-sec-0001}
===============

The Food and Agriculture Organization of the United Nations (FAO) has defined transboundary animal diseases as 'epidemic diseases which are highly contagious or transmissible and have the potential for very rapid spread, irrespective of national borders, causing serious economic and sometimes public health consequences' (Food & Agricultural Organization, [2018](#tbed13356-bib-0026){ref-type="ref"}). Thus, livestock diseases may be responsible for negative social, economic and environmental impacts, at different levels (locally, nationally, regionally and internationally). Hence, the introduction of a new livestock disease not only has an impact on animal health, but also affects international trade, food supply and, if zoonotic, human health (Food & Agricultural Organization, [2018](#tbed13356-bib-0026){ref-type="ref"}).

With the societal and technological changes occurring during the twentieth century, novel pathogens have appeared with countries experiencing human and animal diseases they have never seen before (emergence) or that had been eradicated in the past (re‐emergence). Noteworthy, examples of (re‐)emerging animal diseases are the foot‐and‐mouth disease (FMD) epidemic in the United Kingdom in 2001 (Knowles, Samuel, Davies, Kitching, & Donaldson, [2001](#tbed13356-bib-0032){ref-type="ref"}) and in Japan in 2010 (Muroga et al., [2012](#tbed13356-bib-0039){ref-type="ref"}) and the continuing outbreaks of highly pathogenic avian influenza (HPAI) since 2003--2004 around the world (Elbers et al., [2004](#tbed13356-bib-0017){ref-type="ref"}), the Bluetongue epidemic in Western Europe (Carpenter, Wilson, & Mellor, [2009](#tbed13356-bib-0010){ref-type="ref"}; Wilson & Mellor, [2009](#tbed13356-bib-0044){ref-type="ref"}) and the newly identified Schmallenberg disease in Germany in 2011, which has further spread to other parts of Europe, like the Netherlands, Belgium and Northern Ireland (Afonso et al., [2014](#tbed13356-bib-0001){ref-type="ref"}; Anonimous, [2013](#tbed13356-bib-0004){ref-type="ref"}). Also, in 2016, cases of HPAI were reported to the OIE from different European member states including Belgium (World Organisation for Animal Health, [2018](#tbed13356-bib-0046){ref-type="ref"}). Another very important recent emerging livestock disease reported specifically in Belgium at the end of 2018 was African swine fever, although cases so far have been reported only in wild boars (Linden et al., [2019](#tbed13356-bib-0036){ref-type="ref"}). Its emergence is of great concern for the pig industry of the region and being a disease, which until now has been exotic for Belgium. It shows how diseases may re‐emerge unexpectedly with most likely origin attributable to human activity (Saegerman, [2018](#tbed13356-bib-0040){ref-type="ref"}).

The (re‐)emergence of diseases shifts in relation to several underlying set of factors inherent to modern society, that is the so‐called 'drivers'. The joint presence of these drivers can create an environment in which infectious disease can (re‐)emerge and be maintained in animal and/or human compartments (King, [2004](#tbed13356-bib-0031){ref-type="ref"}). Many drivers have been identified, such as climate change, global travel, immigration patterns, increase in the human population, environmental degradation and others (Altizer, Ostfeld, Johnson, Kutz, & Harvell, [2013](#tbed13356-bib-0003){ref-type="ref"}; Daszak, Cunningham, & Hyatt, [2000](#tbed13356-bib-0015){ref-type="ref"}; King, [2004](#tbed13356-bib-0031){ref-type="ref"}).

The threat of (re‐)emergence is more likely to increase and past experience has shown that no country, however economically well‐developed it may be, is capable of ensuring 100% security of its borders, even by imposing measures such as quarantine protocols or import bans on animals and animal products (Ben Jebara, [2004](#tbed13356-bib-0006){ref-type="ref"}). In Belgium, the monitoring and reporting of livestock diseases are subjected mostly on self‐reporting of suspected clinical cases by the farmers to the Federal Agency for the Safety of the Food Chain (FASFC), with an established list of mandatory notifiable diseases for livestock and other species (aquatic, exotic) (Federal Agency for the Safety of the Food Chain, [2019](#tbed13356-bib-0024){ref-type="ref"}). Each suspicion is then confirmed by laboratory analysis (Federal Agency for the Safety of the Food Chain, [2019](#tbed13356-bib-0024){ref-type="ref"}). Thus, a rational priority setting approach is needed to assist decision‐makers in identifying and prioritize diseases that are more likely to (re‐)emerge and as such allocating the right resources tailored to a particular disease threat. One such approach used is disease prioritization, which has as main objectives: to optimize financial and human resources for the surveillance, prevention, control and eradication of infectious disease and to target surveillance for early detection of any emerging diseases (Humblet et al., [2012](#tbed13356-bib-0030){ref-type="ref"}).

Some studies identified key characteristics of potential emerging infectious diseases and prioritized infectious diseases according to their risk of (re‐)emergence or impact in some countries (Cardoen et al., [2009](#tbed13356-bib-0008){ref-type="ref"}; Cox, Sanchez, & Revie, [2013](#tbed13356-bib-0014){ref-type="ref"}; Havelaar et al., [2010](#tbed13356-bib-0029){ref-type="ref"}; Humblet et al., [2012](#tbed13356-bib-0030){ref-type="ref"}). Hence, these focused on human or zoonotic diseases and the impact they would have in certain countries. In this study, the focus is livestock epidemic diseases and the aim was to identify (re‐)emergence drivers\' criteria and with it use expert elicitation to prioritize livestock epidemic diseases that may emerge in Belgium.

A multicriteria decision analysis (MCDA) method was chosen because it provides a systematic way to integrate information from a range of sources (Cox et al., [2013](#tbed13356-bib-0014){ref-type="ref"}) and it aims to improve transparency and repeatability (European Centre & for Disease Prevention & Control, [2015](#tbed13356-bib-0018){ref-type="ref"}). Multicriteria decision analysis requires identifying criteria and scoring criteria according to the pathogen/disease. By weighting each criterion and calculating weighted scores from the criteria, an overall score per pathogen/disease was calculated (European Centre & for Disease Prevention & Control, [2015](#tbed13356-bib-0018){ref-type="ref"}; Humblet et al., [2012](#tbed13356-bib-0030){ref-type="ref"}).

This is the first study to prioritize livestock epidemic disease using drivers as criteria. This prioritization list could be an aid to decision‐makers to make an informed decision on course of actions to be taken and use the correct resources when there is a threat of a disease (re‐)emerging in Belgium.

2. MATERIALS AND METHODS {#tbed13356-sec-0002}
========================

2.1. Selection of diseases {#tbed13356-sec-0003}
--------------------------

We compiled a list of livestock‐associated infectious diseases (Figure [1](#tbed13356-fig-0001){ref-type="fig"}) using a systematic approach. This was done by collating in a single database notifiable terrestrial animal diseases from different governmental official lists from Belgium (Federal Agency for the Safety of the Food Chain, [2015](#tbed13356-bib-0023){ref-type="ref"}) and neighbouring countries (Luxembourg was excluded because of high similarity), that is Germany (Federal Ministry of Food & Agriculture of Germany, [2015](#tbed13356-bib-0025){ref-type="ref"}), France (Légifrance, [2015a](#tbed13356-bib-0033){ref-type="ref"}, [2015b](#tbed13356-bib-0034){ref-type="ref"}), the Netherlands (Ministerie van Landbouw, [2015](#tbed13356-bib-0037){ref-type="ref"}) and Great Britain (Scottish Government, [2015](#tbed13356-bib-0042){ref-type="ref"}). In order to broaden the spectrum, diseases included in two other lists of official international organizations, that is the World Organisation for Animal Health (OIE) (World Organisation for Animal Health, [2015](#tbed13356-bib-0045){ref-type="ref"}) and the European Union (European Commission, [2012](#tbed13356-bib-0019){ref-type="ref"}), were also added to the database. Only diseases that affect cattle, sheep, goats, swine and poultry (livestock) were selected from the official lists and included in database.

![Systematic process for selecting the livestock diseases. \* Livestock diseases were those which affected cattle, sheep, goats, swine and poultry](TBED-67-344-g001){#tbed13356-fig-0001}

After completion of the database, diseases were excluded if: (a) they were not of the epidemic type; (b) by the time the list was compiled (January 2015) no cases were reported in Belgium over the past year (i.e. during the year 2014). The disease duplicates were removed. Four diseases that were not in any of the official lists were added to the list of diseases for prioritization: Schmallenberg, Aino, Akabane and novel swine enteric coronavirus. Schmallenberg virus is a novel pathogen detected in 2011 in three adjoining countries: Germany, the Netherlands and Belgium, which eventually caused an outbreak in Northern Europe from 2011 to 2013 (Lievaart‐Peterson, Luttikholt, Brom, & Vellema, [2012](#tbed13356-bib-0035){ref-type="ref"}). Aino and Akabane viruses were added because both viruses belong to the same Simbu serogroup of the genus *Orthobunyavirus* of the *Bunyaviridae* family as Schmallenberg virus. Additionally, a number of publications have highlighted that viruses from the Simbu group circulate within the Mediterranean basin (Azkur et al., [2013](#tbed13356-bib-0005){ref-type="ref"}; Chaintoutis et al., [2014](#tbed13356-bib-0012){ref-type="ref"}; Lievaart‐Peterson et al., [2012](#tbed13356-bib-0035){ref-type="ref"}; Yilmaz et al., [2014](#tbed13356-bib-0047){ref-type="ref"}). Thus, the risk of any of these viruses to (re‐)emerge may be present, which further prompted the necessity of adding these three viruses to the list of diseases to be prioritized. The appearance of the novel swine enteric coronavirus disease, first in the United States in February 2014 and later in March 2014 in Ontario Canada (European Food Safety Authority, [2014](#tbed13356-bib-0021){ref-type="ref"}; [2014](#tbed13356-bib-0022){ref-type="ref"}), raised concerns in the European Members States, as this emerging diseases could affect the health status of pig holding in Europe and their production. For this reason, we decided to include it in the final list of epidemic livestock diseases.

### 2.1.1. Questionnaire design {#tbed13356-sec-0004}

The main objective was to prioritize the diseases according to drivers of (re‐)emergence. A driver was defined as a factor, which has the potential to directly or indirectly precipitate ('drive') or lead to the (re‐)emergence of a livestock infectious disease. We identified different criteria considered as drivers through scientific literature and previous disease prioritization exercises, and discussion with experts from academia, government agencies and international bodies.

A total of 50 criteria were identified and classified under 8 different domains (Table [1](#tbed13356-tbl-0001){ref-type="table"}): (A) pathogen/disease characteristics (*N* 9 criteria); (B) distance to Belgium (*N* = 3 criteria); (C) ability to monitor, treat and control the disease (*N* = 7 criteria); (D) farm/production characteristics (*N* = 7 criteria); (E) changes in climate conditions (*N* = 3) criteria; (F) wildlife interface (*N* = 6 criteria); (G) human activity (*N* = 6 criteria); and (H) economic and trade activity (*N* = 9 criteria). The questionnaire was formatted in Excel^®^ (Microsoft, Redmond, WA, USA, 2013) file with one spreadsheet per domain including corresponding criteria with an addition of a last spreadsheet, with the eight listed domains (*N* = 8 domains).

###### 

List of criteria used to prioritise (re)emerging infectious diseases, according to their likelihood of (re)emergence in Belgium in response to different categories of drivers

  ---------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **A. DISEASE/PATHOGEN CHARACTERISTICS**                    
  A.1                                                        Current knowledge on the pathogen
  A.2                                                        Current species specificity of the disease‐causing agent
  A.3                                                        Genetic variability of the infectious agent
  A.4                                                        Transmission of the pathogen in relation to the possible spread of the epidemic
  A.5                                                        Risk of showing no clinical signs and silent spread during infection and postinfection
  A.6                                                        Wild reservoir and potential spread from it
  A.7                                                        Existence of vectors (vertebrates and invertebrates, e.g. mosquitoes, bats, rodents, ticks, culicoid biting midges) and potential spread
  A.8                                                        Transmission of the pathogen
  A.9                                                        Environmental persistence
  **B. DISTANCE TO BELGIUM**                                 
  B.1                                                        Current incidence (cases)/prevalence of the disease in the world
  B.2                                                        European geographic proximity of the pathogen/disease to Belgium
  B.3                                                        To your knowledge, when was the disease last reported in Europe
  **C. ABILITY TO MONITOR, TREAT AND CONTROL THE DISEASE**   
  C.1                                                        Ability of preventive/control measures to stop the disease from entering the country or spreading (containment of the epidemic). Excluding treatment, vaccination and vector(s)/reservoir(s) control
  C.2                                                        Vaccine availability
  C.3                                                        Control of reservoir(s) and/or vector(s)
  C.4                                                        Availability and quality of diagnostic tool(s) in Belgium
  C.5                                                        Disease is currently under surveillance overseas (OIE, EU)
  C.6                                                        Eradication experience in other countries and/or Belgium
  C.7                                                        Detection of emergence, for example difficulties for the farmer/veterinarian to declare the disease or clinical signs not so evident
  **D. FARM/PRODUCTION SYSTEM CHARACTERISTICS**              
  D.1                                                        Mono‐species farms (one single farmed animal species, e.g. only cattle) or multispecies farms (more than one species, e.g. goats and cattle, are raised in the same farm/land/premises)
  D.2                                                        Farm demography/management: such as type of dairy or beef (cattle) production. For pigs---reproduction, fattening, finishing farm or both. Chickens---only laying eggs chickens or solely finishing broilers
  D.3                                                        Animal density of farms. Extensive (small holders with a few animals) v/s intensive farming
  D.4                                                        Feeding practices of farms
  D.5                                                        Human movements among premises---veterinarians or farm staff
  D.6                                                        Proximity of livestock farm to wildlife and wildlife reservoirs of disease, for example contact with wild or feral birds and animals, which have been scavenging on landfill sites that contain contaminated animal products
  D.7                                                        Changes of land use, for example field fragmentation, creation of barriers, landfill sites
  **E. CHANGES IN CLIMATIC CONDITIONS**                      
  E.1                                                        Influence of annual [rainfall]{.ul} on the survival and transmission of the pathogen/disease
  E.2                                                        Influence of annual [humidity]{.ul} on the survival and transmission of the pathogen/disease
  E.3                                                        Influence of annual [temperature]{.ul} on the survival and transmission of the pathogen/disease
  **F. WILDLIFE INTERFACE**                                  
  F.1                                                        Potential roles of zoo\'s in the (re)emergence of the pathogen
  F.2                                                        The rural(farm)--wildlife interface
  F.3                                                        Increase of indigenous wild mammals in Belgium and neighbouring countries
  F.4                                                        Increase in endemic/migrating populations of wild birds
  F.5                                                        Hunting activities: hunted animals can be brought back to where livestock is present
  F.6                                                        Transboundary movements of terrestrial wildlife from other countries
  **G. HUMAN ACTIVITIES**                                    
  G.1                                                        In‐ and out‐people movements linked to tourism
  G.2                                                        Human immigration
  G.3                                                        Transport movements: more specifically commercial flights, commercial transport by ships, cars or military (excluding transport vehicles of live animals)
  G.4                                                        Transport vehicles of live animals
  G.5                                                        Bioterrorism potential
  G.6                                                        Inadvertent release of an exotic infectious agent from a containment facility, for example laboratory
  **H. ECONOMIC AND TRADE ACTIVITIES**                       
  H.1                                                        Decrease in resources allocated to the disease surveillance
  H.2                                                        Modification of the disease status (i.e. reportable disease becoming [not]{.ul} reportable) or change in screening frequency due to a reduced national budget
  H.3                                                        Decrease in resources allocated to the implementation of biosecurity measures at border controls (e.g. harbours or airports)
  H.4                                                        Most likely influence of (il)legal movements of live animals (livestock, pets, horses, etc.) from neighbouring/MSs for the on the disease (re)emergence in Belgium
  H.5                                                        Influence of increased (il)legal imports of animal products such as skin, meat and edible products from MSs on the disease (re)emergence in Belgium
  H.6                                                        Most likely influence of increased (il)legal imports of non‐animal products such as tires, wood, furniture from MSs on the disease (re)emergence in Belgium.
  H.7                                                        Most likely influence of (il) legal movements of live animals (livestock, pets, horses, etc.) from Third countries on the disease (re)emergence in Belgium.
  H.8                                                        Most likely influence of increased imports of animal products such as skin, meat and edible products from Third countries on the disease (re)emergence in Belgium
  H.9                                                        Most likely influence of increased (il)legal imports of NON‐animal products such as tires, wood, furniture from Third countries on the disease (re)emergence in Belgium
  ---------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviation: MS, European Union Member State.
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Each criterion had a definition of the coefficient, which ranged from 0 to 4 accordingly (Appendix [A](#tbed13356-app-0001){ref-type="app"}).

### 2.1.2. Scoring and weighting system {#tbed13356-sec-0005}

Each domain spreadsheet had a number of criteria. For each criterion, coefficients were clearly defined for a good comprehension and standardization. Coefficients were from scores of 0 to 4 or from 1 to 4 (a number of criteria could not be scored with a zero, e.g. current species specificity of the disease‐causing agent). Each spreadsheet included two columns. Experts had to fill both of them. The first one corresponding to the coefficient for the choice for the criterion, and the second one for weighting they gave to the criterion (intradomain weighting). Regarding the weighting system, a Las Vegas method was applied (Gore, [1987](#tbed13356-bib-0028){ref-type="ref"}). The number of points to be distributed was proportional to the number of criteria per category multiplied by ten. Indeed, the criterion with the most points allocated is considered the one that weighs the most in the category. If, on the other hand, all the criteria have the same weight in the category, the distribution is equitable, with 10 points for each criterion. For example, 90 points were to be distributed between the 9 criteria of the 'pathogen characteristics' domain. Indeed, the criterion with the most points allocated is considered the one that weighs the most in the pathogen characteristics. Such process illustrated the experts\' opinion on the relative importance of criteria within one domain.

The last spreadsheet was dedicated to the inter‐domain weighting. Experts were asked to distribute a total of 80 points (*N* = 8 domains) among the domains to classify the domains according to their opinion.

### 2.1.3. Expert elicitation {#tbed13356-sec-0006}

Two rounds of expert elicitation were implemented. The first round consisted in the questionnaire assessment; experts were asked to verify whether the questions were in relation with the drivers and whether the scoring systems were correctly defined and identified. The questionnaire and related instructions were sent to 14 experts (Appendix [B](#tbed13356-app-0002){ref-type="app"}) by e‐mail. The experts were asked to complete questionnaire by scoring and additionally to assess and give comments on the criteria and coefficient definitions. The questionnaire was then refined according to experts\' comments and suggestions.

For the second round, 62 experts were identified (Appendix [C](#tbed13356-app-0003){ref-type="app"}) via Internet searching and recommendations from the project partners and recruited participants. These experts were asked to answer the questionnaire in order to rank the diseases. Thus, they had to choose the defined coefficient for each criterion (i.e. criterion scoring), then distribute the points for within each domain (i.e. the intradomain weighting), and lastly distribute the points within the domains (i.e. inter‐domain weighting).

They were invited to participate via a project summary e‐mail and were sent the reviewed questionnaire via e‐mail if they agreed to participate. Experts were recruited until a minimum of 4 experts per disease was obtained with a maximum of 5 experts. In some cases, one expert could answer several questionnaires (one per disease) if the diseases were within is area of expertise.

2.2. Calculation of total scores for each disease {#tbed13356-sec-0007}
-------------------------------------------------

To obtain the overall score for the ranking, an aggregation method that combined the 2 types of weighting (i.e. the intra‐ and inter‐domain) was used. First, the criterion score (coefficients attributed by experts) had to be standardized. Indeed, some criteria were allocated coefficients from 0 to 4 and others from 1 to 4. This standardized score was then multiplied by the intradomain weight as given by the expert. These results were summed to obtain a domain score.$$\text{DSj} = \sum\text{crit}\left( {\text{SCj} \times \text{WdWj}} \right)$$

In this formula, DSj = domain score, crit = criterion, SCj = standardized score of the criterion and WdWj = intradomain weight for each criterion.

Each domain score was then multiplied by the inter‐domain weight. These results were summed and an overall weighted score calculated, per expert and per disease.$$\text{OWS} = \sum\text{cat}\left( {\text{DSj} \times \text{IdWj}} \right)$$

In this formula, OWS = overall weighting score of each expert for a specific disease, cat = category, DSj = domain score and IdWj = inter‐domain weight.

Each disease had 4 or 5 OWS (since there were 4 or 5 experts per disease), and thus, for each disease, the final score was the average of all disease experts\' OWS. The final score was then used to rank the diseases, based on drivers, from the highest score to the lowest. The highest score corresponded to the disease with the highest risk of (re‐)emerging according to the drivers. In addition, the median and range among the scores of all the disease experts were also obtained. With the median, a ranking was done to observe whether there was any significant difference with the ranking obtained using the mean. The range was used to note which diseases had the highest and lowest level of variation/uncertainty among the final experts\' average score.

2.3. Ranking of the perceived drivers (domains) {#tbed13356-sec-0008}
-----------------------------------------------

In order to determine which driver(s) was/were considered as the most influential for the (re‐) emergence of diseases, the domains were ranked. Domain ranking was performed using the inter‐domain scores (weights). The sum of each domain weight (∑IdWj) per disease and per domain given by each expert was ranked from the high to the low, that is 1 to 8. Then, for each domain, the frequency of their rank was used to display in graph.

2.4. Cluster analysis {#tbed13356-sec-0009}
---------------------

A cluster analysis was implemented using regression tree analysis (Salford Predictive Modeler^®^, Version 8.2, Salford Systems, San Diego, California, USA). The normalized disease score is a continuous variable, and the aim was to obtain groups in qualitative categories of importance (e.g. very high, high, moderate and low) with minimal within‐group variance.

2.5. Sensitivity analysis {#tbed13356-sec-0010}
-------------------------

Two sensitivity analyses were assessed, that is on expert elicitation and influence of a domain. This was achieved by repeating the disease ranking with a 'reduced' version of the model and comparing the new ranking to the complete model.

The experts\' sensitivity analysis consisted in dividing them into 4 groups. Scores were then re‐calculated by deleting a group of experts. Each reduced ranking model was compared to the full complete model by using the Spearman\'s rank test to establish whether the ranking was correlated between the complete and the reduced models.

The sensitivity analysis on the domains was done by deleting one domain and re‐calculating the mean scores to rank the diseases. This 'reduced' ranking was then compared with the complete model, and the Spearman\'s rank test was applied. If the ranking position changed to less than three places, then the final score was considered as robust. If it changed to more than two places, then it was considered as a domain of drivers influencing greatly disease (re‐)emergence.

3. RESULTS {#tbed13356-sec-0011}
==========

3.1. Disease selection {#tbed13356-sec-0012}
----------------------

We compiled a list of 29 diseases (Table [2](#tbed13356-tbl-0002){ref-type="table"}) after applying inclusion and exclusion criteria. Nearly all of them were viral with the exception of three bacterial diseases: contagious bovine pleuropneumonia (CBPP), contagious caprine pleuropneumonia (CCPP) and haemorrhagic septicaemia. Out of the 29 diseases, 13 were caused by arboviruses. Six diseases, that is eastern equine encephalitis (EEE), western equine encephalitis (WEE), Venezuelan equine encephalitis (VEE), Japanese encephalitis, West Nile fever and Nipah disease, were zoonotic.

###### 

List of 29 diseases selected for prioritization, including the family and genus it belongs to and species it affects

+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Name of disease                         | Family                                       | Species affected                         |
+=========================================+==============================================+==========================================+
| Eastern equine encephalitis             | F: *Togaviridae*                             | Wild birds, horses, humans               |
|                                         |                                              |                                          |
|                                         | G: *Alphavirus*                              |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Western equine encephalitis             | F: *Togaviridae*                             | Wild birds, horses, humans               |
|                                         |                                              |                                          |
|                                         | G: *Alphavirus*                              |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Venezuelan equine encephalitis          | F: *Togaviridae*                             | Wild birds, horses, humans               |
|                                         |                                              |                                          |
|                                         | G: *Alphavirus*                              |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Japanese Encephalitis                   | F: *Flaviviridae*                            | Equids, wild birds, humans, swine        |
|                                         |                                              |                                          |
|                                         | G: *Flavivirus*                              |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| West Nile fever                         | F: *Flaviviridae*                            | Wild birds, equids, humans               |
|                                         |                                              |                                          |
|                                         | G: *Flavivirus*                              |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Aino disease                            | F: *Bunyaviridae*                            | Bovines, cervids, sheep                  |
|                                         |                                              |                                          |
|                                         | G: *Orthobunyavirus*                         |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Akabane disease                         | F: *Bunyaviridae*                            | Bovines, goats, sheep                    |
|                                         |                                              |                                          |
|                                         | G: *Orthobunyavirus*                         |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Schmallenberg disease                   | F: Bunyaviridae                              | Bovines, sheep, goats                    |
|                                         |                                              |                                          |
|                                         | G: Orthobunyavirus                           |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Rift Valley fever                       | F: *Bunyaviridae*                            | Sheep, bovines and goats.                |
|                                         |                                              |                                          |
|                                         | G: *Phlebovirus*                             |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| African horse sickness                  | F: *Reoviridae*                              | Equids                                   |
|                                         |                                              |                                          |
|                                         | G: *Orbivirus*                               |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Bluetongue                              | F: *Reoviridae*                              | Bovines, sheep, goats and wild ruminants |
|                                         |                                              |                                          |
|                                         | G: *Orbivirus*                               |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Epizootic haemorrhagic disease          | F: *Reoviridae*                              | Bovines and wild ruminants               |
|                                         |                                              |                                          |
|                                         | G: *Orbivirus*                               |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| African swine fever                     | F: *Asfivirus*                               | Pigs and wild boar                       |
|                                         |                                              |                                          |
|                                         | G: *Asfivirus*                               |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| High pathogenic avian influenza         | F: *Orthomyxoviridae*                        | Poultry, wild birds                      |
|                                         |                                              |                                          |
|                                         | G: *Influenzavirus* A                        |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Low pathogenic avian influenza          | F: *Orthomyxoviridae*                        | Poultry, wild birds                      |
|                                         |                                              |                                          |
|                                         | G: Influenzavirus A                          |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Contagious bovine pleuropneumonia       | *Mycoplasma*                                 | Bovines                                  |
|                                         |                                              |                                          |
|                                         | *Mycoides*                                   |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Contagious caprine pleuropneumonia      | *Mycoplasma capricolum*                      | Goats                                    |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Classic swine fever                     | F: *Flaviviridae*                            | Pigs and wild boar                       |
|                                         |                                              |                                          |
|                                         | G: *Pestivirus*                              |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Foot‐and‐mouth disease                  | F: *Picornaviridae*                          | All cloven‐hoofed animals                |
|                                         |                                              |                                          |
|                                         | G: *Aphthovirus*                             |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Haemorrhagic septicaemia                | *Pasteurella multocida* (Serotypes 6:B, 6:E) | Bovines                                  |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Lumpy skin disease                      | F: *Poxviridae*                              | Cattle                                   |
|                                         |                                              |                                          |
|                                         | G: *Capripoxvirus*                           |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Newcastle disease                       | F: *Paramyxoviridae*                         | Poultry                                  |
|                                         |                                              |                                          |
|                                         | G: *Avulavirus*                              |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Nipah virus encephalitis                | F: *Paramyxoviridae*                         | Pigs                                     |
|                                         |                                              |                                          |
|                                         | G: *Henipavirus*                             |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Novel swine enteric coronavirus disease | F: *Coronaviridae*                           | Pigs                                     |
|                                         |                                              |                                          |
|                                         | G: *Deltacorona Virus*                       |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| *Peste des petits ruminants*            | F; Paramyxoviridae                           | Sheep and goats                          |
|                                         |                                              |                                          |
|                                         | G: *Morbillivirus*                           |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Porcine epidemic diarrhoea              | F: Coronavirus                               | Pigs                                     |
|                                         |                                              |                                          |
|                                         | G: *Alphacoronavirus*                        |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Sheep and goat pox                      | F: *Poxviridae*                              | Sheep and goats                          |
|                                         |                                              |                                          |
|                                         | G: *Capripoxvirus*                           |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Swine vesicular disease                 | F: *Picornaviridae*                          | Pigs                                     |
|                                         |                                              |                                          |
|                                         | G: *Enterovirus*                             |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+
| Vesicular stomatitis                    | F: *Rhabdoviridae*                           | Equids, cattle and goats                 |
|                                         |                                              |                                          |
|                                         | G: *Vesiculovirus*                           |                                          |
+-----------------------------------------+----------------------------------------------+------------------------------------------+

Abbreviations: F, Family; G, Genus.
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3.2. Questionnaire survey {#tbed13356-sec-0013}
-------------------------

All 14 experts contacted for the first phase (questionnaire assessment) answered positively (Appendix [B](#tbed13356-app-0002){ref-type="app"}). There was a general agreement on which criteria and coefficients were clear or not. Neither criterion nor coefficient were deleted but only amended according to experts\' suggestions.

For the second phase of expert elicitation, a total of 62 experts agreed to participate and answered the questionnaires (Appendix [C](#tbed13356-app-0003){ref-type="app"}). The objective of minimum of 4 experts per disease was reached, and the maximum of 5 experts was reached for 8 diseases.

3.3. Ranking of diseases {#tbed13356-sec-0014}
------------------------

The final disease ranking based on the average final scores is shown in Figure [2](#tbed13356-fig-0002){ref-type="fig"}. The higher the mean score, the higher the ranking, which means the disease is most likely to (re‐)emerge in Belgium.

![(Re‐)emerging livestock diseases prioritized. Mean scores and standard deviations are mentioned. Four clusters were identified by regression tree analysis marked by brackets](TBED-67-344-g002){#tbed13356-fig-0002}

The top 5 diseases in decreasing order were porcine epidemic diarrhoea (PED), FMD, low pathogenic avian influenza (LPAI), African horse sickness (AHS) and HPAI (Table [3](#tbed13356-tbl-0003){ref-type="table"}). On the other end, the diseases with the lowest mean scores were haemorrhagic septicaemia, Japanese encephalitis, WNF, *peste des petits ruminants* (PPR) and Nipah disease.

###### 

Ranking and mean scores grouped by regression tree analysis of the 29 diseases according to the base model and the other 'reduced' models

  Disease                                 Regression tree cluster[a](#tbed13356-note-0005){ref-type="fn"}   Deleted domain                                                                                                                                                                                                                                                                                                                                                   
  --------------------------------------- ----------------------------------------------------------------- ---------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- -----------------------------------------------
  Porcine epidemic diarrhoea              1                                                                 \(1\)            \(1\)                                           \(3\)                                           \(3\)                                           (8)[\*](#tbed13356-note-0007){ref-type="fn"}    \(1\)                                           \(1\)                                           \(3\)                                           (5)[\*](#tbed13356-note-0007){ref-type="fn"}
  4,143.38                                3,454.63                                                          3,839.38         3,572.13                                        3,461.81                                        4,124.63                                        4,129.94                                        3,599                                           2,822.13                                                                                        
  Foot‐and‐mouth disease                  1                                                                 \(2\)            (12)[\*](#tbed13356-note-0007){ref-type="fn"}   \(2\)                                           \(1\)                                           \(2\)                                           \(2\)                                           \(2\)                                           (6)[\*](#tbed13356-note-0007){ref-type="fn"}    (8)[\*](#tbed13356-note-0007){ref-type="fn"}
  4,057.36                                2,938.61                                                          3,841.11         3,731.11                                        3,773.01                                        4,007.26                                        3,954                                           3,390.86                                        2,765.56                                                                                        
  Low pathogenic avian influenza          1                                                                 \(3\)            (8)[\*](#tbed13356-note-0007){ref-type="fn"}    \(1\)                                           \(5\)                                           (6)[\*](#tbed13356-note-0007){ref-type="fn"}    \(3\)                                           (23)[\*](#tbed13356-note-0007){ref-type="fn"}   \(2\)                                           \(1\)
  3,974.13                                3,019.5                                                           3,881.13         3,386.88                                        3,467.88                                        3,851.938                                       3,017.06                                        3,609.438                                       3,585.06                                                                                        
  African horse sickness                  1                                                                 \(4\)            \(2\)                                           \(4\)                                           \(2\)                                           (1)[\*](#tbed13356-note-0007){ref-type="fn"}    (10)[\*](#tbed13356-note-0007){ref-type="fn"}   \(3\)                                           (1)[\*](#tbed13356-note-0007){ref-type="fn"}    (25)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,974.1                                 3,370.8                                                           3,797.35         3,578.85                                        3,882.1                                         3,501.1                                         3,837.8                                         3,639.1                                         2,211.6                                                                                         
  Highly pathogenic avian influenza       2                                                                 \(5\)            \(6\)                                           (9)[\*](#tbed13356-note-0007){ref-type="fn"}    \(6\)                                           (10)[\*](#tbed13356-note-0007){ref-type="fn"}   \(6\)                                           (17)[\*](#tbed13356-note-0007){ref-type="fn"}   \(7\)                                           (2)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,804.5                                 3,053.86                                                          3,507.75         3,357.63                                        3,377.94                                        3,684.19                                        3,153.31                                        3,381.375                                       3,115.44                                                                                        
  Contagious bovine pleuropneumonia       2                                                                 \(6\)            \(5\)                                           \(5\)                                           (23)[\*](#tbed13356-note-0007){ref-type="fn"}   (3)[\*](#tbed13356-note-0007){ref-type="fn"}    \(4\)                                           \(6\)                                           \(8\)                                           (11)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,789.35                                3,071.25                                                          3,650.54         2,824.66                                        3,615.98                                        3,761.23                                        3,614.66                                        3,350.6                                         2,636.54                                                                                        
  Sheep and goat pox                      2                                                                 \(7\)            \(7\)                                           \(8\)                                           \(9\)                                           (4)[\*](#tbed13356-note-0007){ref-type="fn"}    \(7\)                                           (4)[\*](#tbed13356-note-0007){ref-type="fn"}    (17)[\*](#tbed13356-note-0007){ref-type="fn"}   (16)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,765.06                                3,045.89                                                          3,514.49         3,186.19                                        3,485.31                                        3,678.81                                        3,736.06                                        3,211.94                                        2,496.75                                                                                        
  Classical swine fever                   2                                                                 \(8\)            (3)[\*](#tbed13356-note-0007){ref-type="fn"}    (11)[\*](#tbed13356-note-0007){ref-type="fn"}   (4)[\*](#tbed13356-note-0007){ref-type="fn"}    (15)[\*](#tbed13356-note-0007){ref-type="fn"}   (5)[\*](#tbed13356-note-0007){ref-type="fn"}    (20)[\*](#tbed13356-note-0007){ref-type="fn"}   (19)[\*](#tbed13356-note-0007){ref-type="fn"}   \(6\)
  3,745.33                                3,280.125                                                         3,402.83         3,550.01                                        3,235.01                                        3,732.2                                         3,045.83                                        3,174.39                                        2,796.89                                                                                        
  Lumpy skin disease                      2                                                                 \(9\)            \(11\)                                          (14)[\*](#tbed13356-note-0007){ref-type="fn"}   \(8\)                                           \(9\)                                           \(9\)                                           (5)[\*](#tbed13356-note-0007){ref-type="fn"}    \(11\)                                          (19)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,691.29                                2,946.05                                                          3,347.29         3,193.24                                        3,455.41                                        3,523.79                                        3,627.79                                        3,326.79                                        2,418.66                                                                                        
  Venezuelan equine encephalitis          2                                                                 \(10\)           (4)[\*](#tbed13356-note-0007){ref-type="fn"}    (6)[\*](#tbed13356-note-0007){ref-type="fn"}    (7)[\*](#tbed13356-note-0007){ref-type="fn"}    (7)[\*](#tbed13356-note-0007){ref-type="fn"}    (20)[\*](#tbed13356-note-0007){ref-type="fn"}   (13)[\*](#tbed13356-note-0007){ref-type="fn"}   (20)[\*](#tbed13356-note-0007){ref-type="fn"}   (24)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,625.75                                3,168.5                                                           3,582.5          3,353.25                                        3,465.75                                        3,093.25                                        3,271.75                                        3,119.5                                         2,325.75                                                                                        
  Contagious caprine pleuropneumonia      2                                                                 \(11\)           \(10\)                                          (7)[\*](#tbed13356-note-0007){ref-type="fn"}    (19)[\*](#tbed13356-note-0007){ref-type="fn"}   \(13\)                                          (8)[\*](#tbed13356-note-0007){ref-type="fn"}    (19)[\*](#tbed13356-note-0007){ref-type="fn"}   \(10\)                                          \(10\)
  3,617.45                                2,952.3                                                           3,516.6          2,920.45                                        3,275.7                                         3,587.45                                        3,049.5                                         3,328.7                                         2,691.45                                                                                        
  Epizootic haemorrhagic disease          2                                                                 \(12\)           (15)[\*](#tbed13356-note-0007){ref-type="fn"}   \(13\)                                          \(14\)                                          (5)[\*](#tbed13356-note-0007){ref-type="fn"}    \(14\)                                          \(12\)                                          (4)[\*](#tbed13356-note-0007){ref-type="fn"}    (20)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,599.63                                2,880.52                                                          3,360.03         3,056.33                                        3,484.88                                        3,319.63                                        3,273.96                                        3,429.13                                        2,392.93                                                                                        
  New swine enteric coronavirus disease   2                                                                 \(13\)           (22)[\*](#tbed13356-note-0007){ref-type="fn"}   (18)[\*](#tbed13356-note-0007){ref-type="fn"}   \(15\)                                          (27)[\*](#tbed13356-note-0007){ref-type="fn"}   \(11\)                                          (7)[\*](#tbed13356-note-0007){ref-type="fn"}    (5)[\*](#tbed13356-note-0007){ref-type="fn"}    (4)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,586                                   2,639.25                                                          3,263.88         3,056.31                                        2,870.69                                        3,499.13                                        3,532.625                                       3,391.625                                       2,848.5                                                                                         
  Bluetongue                              3                                                                 \(14\)           \(14\)                                          (22)[\*](#tbed13356-note-0007){ref-type="fn"}   \(16\)                                          (11)[\*](#tbed13356-note-0007){ref-type="fn"}   \(16\)                                          \(14\)                                          \(15\)                                          (23)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,499.22                                2,885.64                                                          3,112.02         3,028.04                                        3,368.72                                        3,255.22                                        3,260.21                                        3,223.97                                        2,360.72                                                                                        
  Western equine encephalitis             3                                                                 \(15\)           \(13\)                                          (10)[\*](#tbed13356-note-0007){ref-type="fn"}   (10)[\*](#tbed13356-note-0007){ref-type="fn"}   (12)[\*](#tbed13356-note-0007){ref-type="fn"}   (18)[\*](#tbed13356-note-0007){ref-type="fn"}   (25)[\*](#tbed13356-note-0007){ref-type="fn"}   \(16\)                                          (21)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,491.81                                2,909.38                                                          3,404.31         3,110.25                                        3,276.19                                        3,241.81                                        2,892.13                                        3,223.06                                        2,385.56                                                                                        
  African swine fever                     3                                                                 \(16\)           (9)[\*](#tbed13356-note-0007){ref-type="fn"}    (19)[\*](#tbed13356-note-0007){ref-type="fn"}   (11)[\*](#tbed13356-note-0007){ref-type="fn"}   (20)[\*](#tbed13356-note-0007){ref-type="fn"}   (12)[\*](#tbed13356-note-0007){ref-type="fn"}   (24)[\*](#tbed13356-note-0007){ref-type="fn"}   (22)[\*](#tbed13356-note-0007){ref-type="fn"}   (12)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,479.96                                2,963.81                                                          3,181.34         3,072.46                                        3,090.59                                        3,456.71                                        2,933.65                                        3,079.03                                        2,582.15                                                                                        
  Eastern equine encephalitis             3                                                                 \(17\)           (23)[\*](#tbed13356-note-0007){ref-type="fn"}   (12)[\*](#tbed13356-note-0007){ref-type="fn"}   (13)[\*](#tbed13356-note-0007){ref-type="fn"}   (14)[\*](#tbed13356-note-0007){ref-type="fn"}   \(19\)                                          \(18\)                                          (13)[\*](#tbed13356-note-0007){ref-type="fn"}   \(15\)
  3,479.38                                2,600                                                             3,391.88         3,056.88                                        3,263.75                                        3,152.81                                        3,075.313                                       3,280.94                                        2,534.06                                                                                        
  Schmallenberg disease                   3                                                                 \(18\)           (26)[\*](#tbed13356-note-0007){ref-type="fn"}   (23)[\*](#tbed13356-note-0007){ref-type="fn"}   (24)[\*](#tbed13356-note-0007){ref-type="fn"}   \(16\)                                          (21)[\*](#tbed13356-note-0007){ref-type="fn"}   (11)[\*](#tbed13356-note-0007){ref-type="fn"}   (9)[\*](#tbed13356-note-0007){ref-type="fn"}    (3)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,459.19                                2,532.94                                                          3,108.56         2,788.44                                        3,231.38                                        3,071.06                                        3,279                                           3,336.06                                        2,866.88                                                                                        
  Vesicular stomatitis                    3                                                                 \(19\)           \(21\)                                          (15)[\*](#tbed13356-note-0007){ref-type="fn"}   \(18\)                                          \(17\)                                          (15)[\*](#tbed13356-note-0007){ref-type="fn"}   (10)[\*](#tbed13356-note-0007){ref-type="fn"}   (12)[\*](#tbed13356-note-0007){ref-type="fn"}   (26)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,450.4                                 2,667.5                                                           3,342.9          2,953.4                                         3,127.9                                         3,297.4                                         3,310.4                                         3,287.9                                         2,165.4                                                                                         
  Akabane disease                         3                                                                 \(20\)           \(20\)                                          (16)[\*](#tbed13356-note-0007){ref-type="fn"}   (17)[\*](#tbed13356-note-0007){ref-type="fn"}   \(18\)                                          \(22\)                                          (15)[\*](#tbed13356-note-0007){ref-type="fn"}   \(18\)                                          (14)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,444.55                                2,681.93                                                          3,332.05         3,013.19                                        3,108.94                                        2,978.61                                        3,244.55                                        3,211.175                                       2,541.43                                                                                        
  Swine vesicular disease                 3                                                                 \(21\)           (18)[\*](#tbed13356-note-0007){ref-type="fn"}   \(21\)                                          \(20\)                                          (26)[\*](#tbed13356-note-0007){ref-type="fn"}   (13)[\*](#tbed13356-note-0007){ref-type="fn"}   (8)[\*](#tbed13356-note-0007){ref-type="fn"}    \(21\)                                          (17)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,425.25                                2,704.94                                                          3,131.56         2,896.5                                         2,906.5                                         3,400.88                                        3,360.875                                       3,100.25                                        2,475.25                                                                                        
  Aino disease                            3                                                                 \(22\)           (16)[\*](#tbed13356-note-0007){ref-type="fn"}   (17)[\*](#tbed13356-note-0007){ref-type="fn"}   \(21\)                                          (19)[\*](#tbed13356-note-0007){ref-type="fn"}   \(23\)                                          (9)[\*](#tbed13356-note-0007){ref-type="fn"}    (14)[\*](#tbed13356-note-0007){ref-type="fn"}   \(22\)
  3,424.75                                2,784.18                                                          3,306.94         2,853.26                                        3,107.19                                        2,965.38                                        3,313.25                                        3,266.81                                        2,376.25                                                                                        
  NewCastle                               3                                                                 \(23\)           (17)[\*](#tbed13356-note-0007){ref-type="fn"}   \(24\)                                          (12)[\*](#tbed13356-note-0007){ref-type="fn"}   \(25\)                                          (17)[\*](#tbed13356-note-0007){ref-type="fn"}   \(21\)                                          (29)[\*](#tbed13356-note-0007){ref-type="fn"}   (18)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,312.75                                2,722.88                                                          3,107.06         3,059                                           2,934                                           3,242.13                                        3,028.063                                       2,647.75                                        2,448.38                                                                                        
  Rift valley fever                       3                                                                 \(24\)           (28)[\*](#tbed13356-note-0007){ref-type="fn"}   (20)[\*](#tbed13356-note-0007){ref-type="fn"}   \(22\)                                          \(23\)                                          \(24\)                                          (16)[\*](#tbed13356-note-0007){ref-type="fn"}   \(25\)                                          (13)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,303.6                                 2,483.38                                                          3,134.79         2,851.79                                        3,005.85                                        2,954.23                                        3,211.1                                         2,925.48                                        2,558.6                                                                                         
  Haemorrhagic septicaemia                4                                                                 \(25\)           (19)[\*](#tbed13356-note-0007){ref-type="fn"}   \(26\)                                          \(25\)                                          (21)[\*](#tbed13356-note-0007){ref-type="fn"}   \(27\)                                          (22)[\*](#tbed13356-note-0007){ref-type="fn"}   \(23\)                                          (28)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,193.44                                2,683.75                                                          2,973.44         2,759.69                                        3,052.81                                        2,859.06                                        3,019.688                                       2,993.44                                        2,012.19                                                                                        
  Japanese encephalitis                   4                                                                 \(26\)           (29)[\*](#tbed13356-note-0007){ref-type="fn"}   \(25\)                                          (29)[\*](#tbed13356-note-0007){ref-type="fn"}   (22)[\*](#tbed13356-note-0007){ref-type="fn"}   \(28\)                                          \(27\)                                          \(26\)                                          (9)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,169.56                                2,480.31                                                          3,069.56         2,344.56                                        3,010.19                                        2,847.69                                        2,828.313                                       2,860.19                                        2,746.13                                                                                        
  West Nile fever                         4                                                                 \(27\)           \(25\)                                          \(29\)                                          \(26\)                                          (24)[\*](#tbed13356-note-0007){ref-type="fn"}   \(29\)                                          \(28\)                                          (24)[\*](#tbed13356-note-0007){ref-type="fn"}   (7)[\*](#tbed13356-note-0007){ref-type="fn"}
  3,146.47                                2,577.93                                                          2,756.78         2,640.74                                        2,941.07                                        2,738.17                                        2,631.66                                        2,954.97                                        2,783.97                                                                                        
  *Peste des Petits Ruminants*            4                                                                 \(28\)           (24)[\*](#tbed13356-note-0007){ref-type="fn"}   \(27\)                                          \(27\)                                          \(28\)                                          (25)[\*](#tbed13356-note-0007){ref-type="fn"}   \(26\)                                          \(28\)                                          \(29\)
  2,989.31                                2,585                                                             2,812.75         2,523.06                                        2,684                                           2,953.38                                        2,883.688                                       2,748.38                                        1,734.94                                                                                        
  Nipah Virus                             4                                                                 \(29\)           \(27\)                                          \(28\)                                          \(28\)                                          \(29\)                                          (26)[\*](#tbed13356-note-0007){ref-type="fn"}   \(29\)                                          \(27\)                                          \(27\)
  2,936.56                                2,486.19                                                          2,795.31         2,498.94                                        2,514.69                                        2,919.69                                        2,500.813                                       2,796.88                                        2,043.44                                                                                        

Highlighted numbers represent an up or down movement of more than 3 steps in the ranking.

Regression tree analysis clusters group: 1 = very high importance; 2 = high importance; 3 = moderate importance; and 4 = low importance.

Base model of the ranking.

Denotes more than three changes in the ranking.
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When comparing the ranking obtained using the average of the scores of the experts and the ranking obtained with the median of the experts\' score, the Spearman\'s test, a Rho of 0.8044, was obtained (*p*‐value .05), showing that there was a significant correlation in both rankings (Appendix [D](#tbed13356-app-0004){ref-type="app"}). However, important change in the ranking for 4 diseases (CBPP, CCPP, Bluetongue and Newcastle) was noted (Appendix [D](#tbed13356-app-0004){ref-type="app"}). The range obtained showed that the 4 highest range values (i.e. the diseases which experts had a high disagreement on their (re)emergence in Belgium) were CBPP, CCPP, vesicular stomatitis and Nipah virus (Figure [2](#tbed13356-fig-0002){ref-type="fig"}). On the other end, the 5 smallest range values were novel swine enteric coronavirus disease, HPAI, haemorrhagic septicaemia, CSF and Schmallenberg virus (Figure [2](#tbed13356-fig-0002){ref-type="fig"}).

3.4. Cluster analysis {#tbed13356-sec-0015}
---------------------

The regression tree analysis determined 4 clusters (Figure [2](#tbed13356-fig-0002){ref-type="fig"}). The clusters distinguished five, eleven, nine and four diseases, and were classified, respectively, as of 'low importance', 'moderate importance', 'high importance' and 'very high importance' (i.e. highly influenced by drivers). The diseases belonging to the node 'highest importance' were PED, FMD, LPAI and AHS. The node of the lowest importance included haemorrhagic septicaemia, Japanese encephalitis, PPR, Nipah disease and WNF.

3.5. Drivers influence {#tbed13356-sec-0016}
----------------------

The relative importance of the 8 domains varied depending on the disease. However, when considering all domains for all 29 diseases, 'economy and trade activities' obtained the highest number of points, being ranked first 15 times and zero times last ranked (8th). The opposite can be said about 'characteristics of farm/production system', as it was never ranked 1st nor 2nd (Figure [3](#tbed13356-fig-0003){ref-type="fig"}).

![Frequency of rank (from 1 to 8) for each domain. (a) Disease/pathogen characteristics; (b) distance to Belgium; (c) ability to monitor, treat and control the disease; (d) farm/production system characteristics; (e) changes in climatic conditions; (f) wildlife interface; (g) human activity; and (h) economic and trade activity. Colour of each bar: white (ranked 1st) until black (ranked 8th)](TBED-67-344-g003){#tbed13356-fig-0003}

3.6. Sensitivity analysis {#tbed13356-sec-0017}
-------------------------

The sensitivity analysis done on the groups of experts showed that the ranking of diseases was not affected in the reduced models. Indeed, the Spearman\'s rank‐order correlation indicated a strong positive association of ranks when using different groups of experts for different reduced models, showing that there was a consistency among the scoring of the experts.

As for the domain sensitivity analysis, Table [3](#tbed13356-tbl-0003){ref-type="table"} displays the mean scores and ranking of the diseases without the scores. The domain that showed the strongest influence on the ranking of a disease (changing the ranking of a disease for more than 3 spots) was 'economic and trade activity'. When discarding that domain, 22 diseases moved three places up or down in the ranking. The Spearman rank correlation test for comparing the base model with the reduced model without the 'economic and trade activity' showed a 0.42‐Rho (*p* \< .05).

Figure [4](#tbed13356-fig-0004){ref-type="fig"} illustrates the movements of the top 5 diseases after performing the sensitivity analysis. When discarding the domain (A) (pathogen characteristics), FMD moved from the 2nd to the 6th place in the ranking, thus highlighting the strong influence of the domain (A) on that specific disease. The ranking of AHS changed notoriously without 'economy and trade activities' (domain H), moving from the 4th to the 25th place. Low pathogenic avian influenza was also strongly influenced, lowering from the 4th to the 23rd place, in the model without the wildlife interface domain.

![Sensitivity analysis for the five diseases with highest mean scores; the graph illustrates their up or down movements in the ranking. \*Ranking changed by more than 3 positions. (A) Disease/pathogen characteristics; (B) distance from Belgium; (C) ability to monitor, treat and control the disease; (D) farm/production system characteristics; (E) changes in climate change; (F) wildlife interface; (G) human activity; and (H) economic and trade activity. AHS, African horse sickness; FMD, foot‐and‐mouth disease; HPAI, high pathogenic avian influenza; LPAI, low pathogenic avian influenza; PED, porcine epidemic diarrhoea](TBED-67-344-g004){#tbed13356-fig-0004}

4. DISCUSSION {#tbed13356-sec-0018}
=============

The MCDA approach allowed the selection of 29 livestock diseases exotic to Belgium and their prioritization based on drivers. Whilst such an approach was used in previous disease prioritization exercises, this is one of the first to consider livestock epidemic diseases only and to use criteria related to drivers of (re‐)emergence. Only diseases exotic to Belgium were prioritized.

The diseases that fitted the eligibility criteria were all of viral origin, except haemorrhagic septicaemia (*Pasteurella multocida*, serotypes 6:B, 6:E), CCPP and CBPP. Few zoonoses were included in the list (*n* = 6) as the prioritization exercise focused on livestock epidemic diseases. Therefore, several zoonoses included in other prioritization processes were excluded.

Regarding prioritization, PED ranked top of the list. Although currently not reportable neither in the EU (except in the UK) nor to the OIE, it ranked high in all models (high mean score), possibly due to its highly transmissible character and the difficulty to control it; furthermore, the disease mainly concerns intensive production. Cases have already been reported in EU Member States: for example in May 2014, an outbreak of diarrhoea occurred in fattening pigs on German farms. An outbreak of diarrhoea occurred on a Belgian fattening pig farm at the end of January 2015; this was the first confirmed PED case in Belgium in decades (Theuns et al., [2015](#tbed13356-bib-0043){ref-type="ref"}). When the list of diseases was compiled, the outbreak had not occurred yet, but when the experts answered the questionnaire it had, and therefore, this was most likely the reason why it ranked at the top of the prioritized list.

Low pathogenic avian influenza ranked slightly higher than HPAI in this multicriteria analysis on the risk of (re)‐emergence (LPAI ranked 3rd whilst HPAI ranked 5th). However, by the time this paper was written, no cases of LPAI were registered on the OIE WAHIS interface for Belgium (World Organisation for Animal Health, [2018](#tbed13356-bib-0046){ref-type="ref"}), whereas HPAI was detected in Hungary in October 2016 and later in 19 other Member States: Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Luxembourg, the Netherlands, Poland, Slovakia, Spain, Sweden, Romania and the United Kingdom (European Commission, [2018](#tbed13356-bib-0020){ref-type="ref"}). Low pathogenic avian influenza shows less signs and symptoms than the HPAI, and the vast majority of LPAI viruses are maintained in asymptomatic wild birds (Center for Food Security & Public Health, [2015](#tbed13356-bib-0011){ref-type="ref"}); thus, an incursion of LPAI in an area free of the virus is more likely to happen and go undetected. Additionally, the HPAI viruses can evolve directly from low pathogenic (LPAI) virus precursors following introduction into domestic poultry (Monne et al., [2014](#tbed13356-bib-0038){ref-type="ref"}). Hence, these characteristics of the virus give in this prioritization LPAI a higher score than HPAI, but HPAI is more likely to be detected and notified.

African horse sickness surprisingly ranked 4th, although its last know incursion in Europe (Portugal and Spain) was in 1987 and its eradication dates back to 1990. Such high position in the ranking could be related to its vector‐borne transmission, that is by *Culicoides* biting midges. These vectors are often highly abundant, across most of Africa, the Middle East, Europe and southern Asia (Carpenter, Mellor, Fall, Garros, & Venter, [2017](#tbed13356-bib-0009){ref-type="ref"}). Additionally, the recent changes in the epidemiology of bluetongue and its latest epidemic in Europe and the emergence of Schmallenberg disease (Afonso et al., [2014](#tbed13356-bib-0001){ref-type="ref"}; Anonimous, [2013](#tbed13356-bib-0004){ref-type="ref"}; Carpenter et al., [2009](#tbed13356-bib-0010){ref-type="ref"}; Wilson & Mellor, [2009](#tbed13356-bib-0044){ref-type="ref"}) highlight the uncertainty about the variables controlling the spread and persistence of *Culicoides*‐borne arboviruses. These different factors have raised concerns that AHS may also amount similar incursions, hence explaining such high mean final score in the prioritization process.

In this prioritization, most of the diseases were in clusters 2 (high importance, *N* = 9) and 3 (moderate importance, *N* = 11). Cluster 2 of high importance includes the diseases HPAI, CSF, LSD, sheep and goat pox and CBPP, all of which have been well described in the past, have had epidemics and still have important outbreaks worldwide. The new swine enteric coronavirus disease, which was added on interest basis, also belongs to this cluster. The three diseases that were added to the prioritization although not present in any of the official list of notifiable diseases, Aino, Akabane and Schmallenberg, were categorized in cluster 3, even though only Schmallenberg has had outbreaks in Europe. It is therefore considered that the Simbu serogroup could be of moderate importance in (re‐)emerging.

From the complete list of the livestock diseases prioritized, it is important to highlight ASF. In this prioritization, ASF did not obtain the highest ranking score at 16th place and placed in the group of moderate importance of the regression tree analysis. However, ASF has become more prevalent in the Caucasus regions since its spread from eastern Africa to Georgia in 2007 and the virus reached the European Union member states of Estonia, Latvia, Lithuania and Poland; in 2016, Moldova; in 2017, the Czech Republic and Romania (Chenais, Ståhl, Guberti, & Depner, [2018](#tbed13356-bib-0013){ref-type="ref"}); and in 2018, the Hungary and Bulgaria. It emerged in Belgium in September of 2018 when authorities in Belgium reported that ASF had been confirmed in 2 wild boars (Linden et al., [2019](#tbed13356-bib-0036){ref-type="ref"}). The detection of ASF in Belgium was unexpected as ASF appears to have jumped a considerable distance from previously affected countries: \~500 km from the border with the Czech Republic, 800 km from Hungary and 1,200 km from the border with Romania (Garigliany et al., [2019](#tbed13356-bib-0027){ref-type="ref"}) and how it was introduced in the wild boar population until the writing this article is unknown (presumably related to illegal human activities) (Saegerman, [2018](#tbed13356-bib-0040){ref-type="ref"}). The ASF score (ranked 16th place and was in group of moderate importance of the regression tree analysis) may be explained that although there was an awareness of the risk of ASF spreading to EU member states, when the questionnaire was answered by the experts (year 2016) the risk that ASF would become endemic in domestic pigs in Ukraine and Belarus was considered to be moderate and the risk to further spread into unaffected areas was also considerate moderate (European Food Safety Authority, [2014](#tbed13356-bib-0021){ref-type="ref"}; [2014](#tbed13356-bib-0022){ref-type="ref"}). Furthermore, the score reflected the geographical position of where ASF had been reported and it was unexpected that ASF skipped neighbouring countries and directly entered Belgium (Garigliany et al., [2019](#tbed13356-bib-0027){ref-type="ref"}). In addition, any ranking cannot include unforeseen circumstances such as the human factors; the vigilance should be always implemented for new introduction.

This score can only be compared with the prioritization work done by Humblet and collaborators (Humblet et al., [2012](#tbed13356-bib-0030){ref-type="ref"}) as other prioritization works using the MCDA method, such as those by Cardoen et al. ([2009](#tbed13356-bib-0008){ref-type="ref"}), and Havelaar et al. ([2010](#tbed13356-bib-0029){ref-type="ref"}), only included zoonoses. Indeed, in regression tree analysis of prioritized diseases of food‐producing animals and zoonoses, ASF also fell in the 3th group of importance out of the 4th group (Humblet et al., [2012](#tbed13356-bib-0030){ref-type="ref"}), just like in this prioritization work. Another study, which may be used for comparison as it used MCDA approach and had swine diseases, done by Brookes, Hernandez‐Jover, Cowled, Holyoake, and Ward ([2014](#tbed13356-bib-0007){ref-type="ref"}), ASF ranked higher, but in this study only exotic diseases for the pig industry in Australia were ranked using criteria related to impact and the experts were pig producers, which changes the importance in the scores, giving ASF a higher ranking.

The livestock diseases at the bottom of the list were Nipah disease, PPR, WNF, Japanese encephalitis and haemorrhagic septicaemia. In other prioritization exercises, Nipah, Japanese encephalitis and WNF were ranked in a higher category (Cox et al., [2013](#tbed13356-bib-0014){ref-type="ref"}; Havelaar et al., [2010](#tbed13356-bib-0029){ref-type="ref"}; Humblet et al., [2012](#tbed13356-bib-0030){ref-type="ref"}). The prioritization model presented here was based on criteria reflecting only drivers; no criteria linked to societal or economic impacts were considered, which affects the weights given to the different domains. Therefore, diseases that otherwise would have scored high in the ranking were in the lower end ('low importance' group in the regression tree analysis). Moreover, until recently only WNF had been reported in Europe (Sambria et al., [2013](#tbed13356-bib-0041){ref-type="ref"}). However, when writing the results of this article, in June 2018, Bulgaria reported the first outbreak in the European Union of PPR, in farms close to the border with Turkey (Altan, Parida, Mahapatra, Turan, & Yilmaz, [2018](#tbed13356-bib-0002){ref-type="ref"}). Thus, although PPR here is in the low importance group, this unexpected introduction would make this disease become suddenly a priority.

Drivers are a complex set of factors, and their convergence can cause the (re‐)emergence of a disease. Several drivers have a stronger impact on diseases compared to others, as shown in the results section. Porcine epidemic diarrhoea ranked at the top in all models, except in the reduced models of production system characteristics. Porcine epidemic diarrhoea affects mainly intensive production systems; thus, the driver category 'production system characteristics' logically influences a lot. When using the reduced model, the mean score decreases and the disease moved from the 1st place to the 8th place. In comparison, FMD ranked high in the prioritization process (2nd), but lowered to the 12th place in the reduced model, which excluded disease pathogen characteristics. For FMD, the strongest driver was the 'pathogens characteristics'. The virus is highly contagious, spreads via airborne and direct contact and affects different livestock species, giving this driver category a strong weight.

All experts considered that 'economy and trade activities' was the most important driver (high weight). It was ranked first more often than others. In the reduced model (without the 'economy and trade activities' domain), all diseases with the exception of 7 moved up or down in the ranking by more than 3 places. This is of no surprise, as economic and trade activity has priority in the age of globalization; increased movement of live animals and animal products crossing oceans and international boundaries increase the risk of spread for animal and zoonotic diseases (Domenech, Lubroth, Eddi, Martin, & Roger, [2006](#tbed13356-bib-0016){ref-type="ref"}). On the other side of the scale, the domain defined as 'characteristics of farm/production system' was given the least weight, therefore with the least influence. Although this true for many diseases within the EU Member States, it is important to consider that for some other diseases in certain cases this domain could be a strong influence. One example is farms, which may have backyard pigs, with no biosecurity set in place and not always under the full control of veterinary services. This type of farming could well explain the dissemination of diseases such as ASF, thus making characteristics of farm/production an importance driver.

As only diseases exotic to Belgium were considered, the results presented here are specific to the country. Nevertheless, a similar prioritization exercise could be applied to other countries, in particular EU Member States, because their animal sanitary status, regulations and controls are similar. Indeed, the focus of the questionnaire was to prioritize diseases according to their drivers and not to the impact on the country nor other criteria country‐specific. Furthermore, the sensitivity analysis of experts also showed a high correlation among the ranking of models, which confirms that experts were in agreement in regards to the scores.

Overall, the importance of validating each generated model is highlighted. Two types of validations can be used. This involves testing the internal validity of the model (e.g. by performing a sensitivity analysis on the domains of criteria and/or testing the effect of deleting groups of experts on the results) and the external validity of the model (e.g. comparing results of each model with other driver‐based prioritization exercises if they exist).

The tool provided here clearly defines each criterion and its coefficients in order to ensure standardization of answers. Although this study cannot account for the complexity of drivers in the (re‐)emergence of a disease, it can provide, through a quick assessment, a general picture of what drivers can influence the (re‐)emergence of a disease. Furthermore, this MCDA tool, which could be made available to third parties upon request to the main authors, can be used with a subset of criteria and/or impact criteria or public health aspects can be easily added, and it could be applied to a broader set of diseases. The resulting scores could be translated into practical recommendations tailored to the needs of a specific country\'s national public or governmental agencies.
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Domains which each defined criterion and their respective defined coefficients (scores) {#tbed13356-sec-0022}
=======================================================================================

**DOMAIN A. DISEASE/PATHOGEN CHARACTERISTICS**A1Current knowledge of the pathogenScore 0Score 1Very high: deep scientific knowledge on the pathogen, extensive scientific literature available on its biology (transmission mode, knowledge on vector(s), infectivity, etc.)Score 2High: detailed scientific knowledge on the pathogen but conflicting scientific results; some elements of the pathogen\'s biology are still not elucidatedScore 3Moderate: limited scientific knowledge on the pathogen agent because it is still under characterization; pathogen recently discovered/isolated but belonging to a well‐known and studied family of pathogens; the pathogen is characterized by multiple variants not characterized yetScore 4Low: lack of scientific knowledge on the pathogen (multiplication, infectivity, incubation period, transmission mode, etc.); pathogen agent recently discovered and emergingA2The current species specificity of the causing agent of the diseaseScore 0Score 1Low. Only one host is involved belonging to the same family, for example only bovines, only equines, only avian, only porcinesScore 2Medium: two species involvedScore 3High: three species involvedScore 4Very high: affects more than 3 types of familiesA3Genetic variability of the infectious agentScore 0Negligible. The infectious agent is genetically stableScore 1Low. The genetic variability is low; therefore, it has a low effect in the (re)emergence of the pathogenScore 2Medium The pathogen can be considered with a medium genetic variability.Score 3High. The pathogen is considered with a high genetic variabilityScore 4Very high. Very high genetic instability (e.g. high mutation rate, re‐assortment and recombination). Potentially, the three phenomena can characterize the pathogen\'s evolutionA4Transmission of the agent in relation of the possible spread of the epidemic (i.e. ease/speed of spread)Score 0Score 1Low: Low and slow transmission within farms. Between farms only if an infected animal is introduced, close contactScore 2Medium: Medium ease/speed transmission within the farm. Between farms mediumScore 3High. Fast transmission within a farm. In a short period of time, all animals of the farm are infected. Adjacent farms become infected fastScore 4Very High. Very fast and high transmission within the farms and between farms. A complete area is infected in a very short period of time.A5Risk of showing no clinical signs and silent spread during infection and post infectionScore 0Null: Silent spread is not part of the pathogen\'s characteristicsScore 1Low: Very short incubation period and signs of infections easily detected/recognized.Score 2Moderate: Very short incubation period and signs of infection are [NOT]{.ul} easily detected/recognizedScore 3Medium: Long incubation period, clinical signs are not characteristics and therefore specific diagnosis is necessary to detect infection.Score 4Very high. Long incubation period. Disease/infection shows not clinical symptoms during the infectious period. Chronic shedderA6Wildlife reservoir and potential spread from itScore 0Null: No known wildlife reservoir. Disease has never been reported in wildlife speciesScore 1Low: Few clinical cases have been reported in wildlife and no transmission to livestock has ever been documented.Score 2Moderate: Wildlife is a reservoir of the disease but only accidental spill overs to livestock have been reported.Score 3High: Wildlife is a reservoir for the pathogen/disease but certain environmental conditions (e.g. floods, farms crossing the farmland‐bush division) have to occur for the pathogen/disease to (re)emerge in livestock.Score 4Very high: Disease establishes itself in wildlife as a reservoir and very hard to eradicate it from wildlife. Livestock easily gets infected with the contact with wildlife.A7Existence of vectors (vertebrate and invertebrate, for example mosquitoes, bats, rodents, ticks, midges, culicoids) and potential spread.Score 0Null: No known vectorScore 1Low: Only one type of vector is present in the country but it\'s role in the transmission is presumed low (has not been assessed to date).Score 2Moderate: Only one type of vector exists in the country and has only been suspected as source and spread of diseaseScore 3High: Only one competent vector is present and can carry and spread the diseaseScore 4Very high: More than one type of vector can carry and spread the disease and are found spread in most of the territoryA8Transmission of the pathogen.Score 0Score 1Low: Animals only get infected by [direct]{.ul} close contact with other infected animals and vertical transmission.Score 2Moderate: Transmission by [direct]{.ul} and [indirect]{.ul} contact only (e.g. through vehicles, clothes, instruments) or non flying vector (e.g. ticks).Score 3High: Exclusively vector transmission by flying vectors (e.g. culicoides, mosquitoes)Score 4Very high: More than three modes of transmission and/or airborne transmissionA9Environmental persistenceScore 0Null: Pathogen does not survive in the environmentScore 1Low: Only anecdotal isolation of the pathogen from the environment has been recordedScore 2Moderate: The survival of the agent in the environment is limited (only temporary) and it\'s dependent on certain environmental conditions such as humidity, temperature and rainfall.Score 3High: The survival of the agent in the environment is limited (only temporary)and [NOT]{.ul} dependent on certain environmental conditions such as humidity, temperature and rainfallScore 4Very high: Agent naturally surviving in the environment (soil, water) and organic materials were it has a long‐term survival.

Number of Criteria = 9, hence 90 points to be distributed within this domain for the intra‐domain weighing.

**DOMAIN B. DISTANCE TO BELGIUM**B1Current incidence (cases)/prevalence of the disease in the worldScore 0Score 1Pathogen has been reported only in the countries of the Australasia (Australia, New Zealand, New Guinea and Neighbouring Pacific Islands) regionScore 2Disease was reported in countries of the Americas, Caribbean and Asia (excluding the Russian Federation)Score 3Disease was reported/present in the African continentScore 4Disease was reported in countries of the Mediterranean Basin, Middle East and the Russian FederationB2European geographic proximity of the pathogen/disease to BelgiumScore 0Score 1Disease has never been present in EuropeScore 2Disease has been reported in Europe in the past but is currently exotic.Score 3Disease is currently present in at least one European country which is NOT bordering BelgiumScore 4Diseases is currently present in at least one of the countries bordering BelgiumB3To your knowledge when was the disease last reported in EuropeScore 0More than 20 years agoScore 1More than 10 years agoScore 2More than 5 years agoScore 3More than 1 year agoScore 4Currently present in Europe

Number of Criteria = 3, hence 30 points to be distributed within this domain for the intra‐domain weighing.

**DOMAIN C. ABILITY TO MONITOR, TREAT AND CONTROL THE DISEASE**C1Ability of preventive/control measures to stop the disease from entering the country or spreading (containment of the epidemic), [EXCLUDING]{.ul} treatment, vaccination and vector(s)/reservoir(s) controlScore 0Score 1Very High Sanitary certificate; effective traceability of animals and by‐products; effective disinfection measures; no contact between domestic and wild animals; effective biosecurity measuresScore 2High No sanitary certificate; effective traceability of animals and by‐products; effective disinfection measures; limited or incomplete possibilities to restrict contacts between domestic and wild animals; effective biosecurity measuresScore 3Low No sanitary certificate; incomplete traceability of animals and by‐products; ineffective disinfection measures; incomplete restriction of contacts between domestic and wild animals; ineffective biosecurity measuresScore 4Very low No sanitary certificate; no traceability of animals and by‐products; ineffective disinfection measures; impossibility to restrict contact between farms or between domestic and wild animals; biosecurity measures totally ineffectiveC2Vaccine availabilityScore 0Score 1Very high Commercialized vaccine available on a global scale (worldwide)Score 2High [Local/mono‐species]{.ul} vaccine available at a regional/national scale and/or for a targeted species (not systematically available for a global fight plan)Score 3Low [Experimental vaccine]{.ul}, not commercialized to date; severe adverse reaction when applied; limited protector effectScore 4Very low [Absence]{.ul}; no vaccine available on the market for a use in the species considered in the study, no experimental vaccine eitherC3Control of reservoir(s) and/or vector(s)Score 0Null No vector‐borne transmission and/or no reservoir(s) known to dateScore 1Very high Effective. Limited reservoir(s) with limited geographical repartition, easy‐to‐identify; high scientific knowledge on vector(s)/reservoir(s); [effective]{.ul} fighting measuresScore 2High Limited reservoir(s)/vector(s) with limited geographical repartition; easy‐to‐identify, high scientific knowledge on vector(s)/reservoir(s); effective fighting measures but [NOT]{.ul} applicable at a large scale; [limited]{.ul} fighting measuresScore 3Low Numerous reservoirs vectors identified with limited geographical repartition; hard to identify. Lack of scientific knowledge on vector(s)/reservoir(s).Fighting measures are [poorly]{.ul} effective ‐ resistances and/or negative impact on environment;Score 4Very low Numerous Vector(s)/reservoir(s)identified with [wide]{.ul} geographic distribution; hard to identify, absence of scientific knowledge on vector(s)/reservoir(s); [NO]{.ul} effective fighting measure against vector(s) (no active molecule, resistance to measures applied)C4Availability and quality of diagnostic tools in BelgiumScore 0Score 1Very High Field test(s) available and easy to use, with highly discriminating sensitivity and specificityScore 2High Tests used in local/regional laboratories by not in the fieldScore 3Low tests only used in *specialized* laboratories/national reference laboratoryScore 4Very Low no diagnostic tools available to dateC5Disease is currently under surveillance overseas (OIE, EU)Score 0Score 1Very high: Generalized surveillance implemented by ALL EU Member States and worldwide surveillance (i.e. OIE reported)Score 2High Surveillance of the pathogen [only]{.ul} EU member statesScore 3Low Surveillance only in some EU member states (because they had cases of the disease) and only in some NON‐EU countries (not a disease reported in any international organizations)Score 4Very low [Absence]{.ul} of surveillance of the pathogen in ALL EU member countries AND world wideC6Eradication experience in other countries and/or BelgiumScore 0Score 1Very high Previous experience on eradication has been applied, fast and successfullyScore 2High Previous experience on eradicating the disease but with some setbacks in the processScore 3Low Knowledge on eradication procedures but have never had to implement an eradication program in BelgiumScore 4Very low It is a novel disease, first time countries are faced with a new disease to eradicateC7Detection of emergence---for example difficulties for the farmer/veterinarian to declare the disease or clinical signs not so evident.Score 0Score 1Very high Disease is easily detected with clinically signs and farmers are aware of the disease and willing to notify it as soon as possible itScore 2High Disease is easily detected by the clinical signs but farmers don\'t have sufficient knowledge/awareness nor interest to notify itScore 3Moderate Disease is not as easily detect by the clinical signs and farmers don\'t have sufficient knowledge/awareness nor interest to notify.Score 4Low The infected animal does not show any pathognomonic clinical sign(s); farmer is reluctant to declare/notify any abnormality.

Number of Criteria = 7, hence 70 points to be distributed within this domain for the intra‐domain weighing.

**DOMAIN D. FARM/PRODUCTION SYSTEM CHARACTERISTICS**D1Mono species farms---One single farmed animal (e.g. only bovines) or multi species farms (farms with more than one species, for example goats and bovines in the same farm/land/premises).Score 0Score 1Negligible: the type of farm does not influence in any form (re)emergence of the disease among the livestock population.Score 2Low: mono or multi species farm has a low effect on the risk of disease to emerge or re‐emerge.Score 3Moderate: the type or types of farmed animals has a moderate effect on the emergence of the disease in Belgium.Score 4High: the type of farmed animals has a high influence for the disease to emerge and spread in Belgium.D2Farm demography/management: such as type of dairy or beef (cattle) production. For pigs---reproduction, fattening, finishing farm or both. Chickens---only laying eggs chickens or solely finishing broilersScore 0Score 1Negligible: population demography does not influence in any form the (re)emergence of the disease among the livestock population.Score 2Low: the demographic population of the farm is a low influencing factor for disease (re)emergence. For example, disease only clinically affects only one age strata (i.e.) newborns, therefore adults are immune to it.Score 3Moderate: the demographic of the population has a moderate effect on the (re)emergence of the disease, as it can (re)emerge in more than one type of demography but other conditioning factors have to occur in conjunction.Score 4High: the type of demographic of the farm has a high effect on the (re)emergence of the disease as it can (re)emerge in different types of farmed animals and all types of age groupsD3Animal density of farms. Extensive (small holders with a few animals) v/s intensive farmingScore 0Score 1Negligible: animal farm density is not a risk factor for the disease to emerge in BelgiumScore 2Low: farm density (extensive or intensive) of animals has a [low effect]{.ul} on the pathogen\'s/disease (re)emergenceScore 3Moderate: farm density of animals in the farm (extensive v/s intensive) has a moderate effect on the emergence of pathogen/diseaseScore 4High: farm density of animals has a high effect on the (re)emergence of pathogen/disease.D4Feeding practices of farmsScore 0Score 1Negligible: Feeding practices have a negligible effect on the (re)emergence of the pathogen/diseaseScore 2Low: Feeding practices have a low effect on the (re)emergence of the pathogen/diseaseScore 3Moderate: Feeding practices have a moderate effect on the (re)emergence of the pathogen/diseaseScore 4High: Feeding practices have a high effect on the (re)emergence of the pathogen/diseaseD5Human movements among premises ‐ Veterinarians or farm staff.Score 0Score 1Negligible: Disease is spread by other meansScore 2Low: Movement of human staff has a low effect on the introduction or spread of the diseaseScore 3Moderate: Movement of human staff has a moderate effect on the introduction or spread of the diseaseScore 4High: Movement of human staff has a high effect on the introduction or spread of the diseaseD6Proximity of livestock farm to wildlife and wildlife reservoirs of disease, for example contact with wild or feral birds and animals which have been scavenging on landfill sites that contain contaminated animal productsScore 0Score 1Negligible: Disease (re)emergence from wildlife and wildlife reservoir never reported.Score 2Low: Disease (re)emergence from wildlife and wildlife reservoir rarely reported.Score 3Moderate: Disease (re)emergence from wildlife and wildlife reservoir is documented regularly.Score 4High: wildlife is a reservoir for the disease and the main source of infection for livestock.D7Changes of land use, for example field fragmentation, creation of barriers, landfill sites.Score 0Score 1Negligible: Changes in land use have a negligible effect on the (re)emergence of pathogen/disease.Score 2Low: changes in land use have a low effect on the (re)emergence of the disease/pathogen but need other factors (e.g. land use changes combined with higher winter temperatures)Score 3Moderate: land use changes increases the availability of vectors or increases the pathogen\'s survival. Also empty land can create a suitable environment for certain wildlife carrying the disease (e.g. migratory birds)Score 4High: land use changes are one of the main drivers for pathogen or its vectors

Number of Criteria = 7, hence 70 points to be distributed within this domain for the intra‐domain weighing.

**DOMAIN E. CHANGES IN CLIMATIC CONDITIONS**E1Influence of annual [rainfall]{.ul} in the survival and transmission of the pathogen/diseaseScore 0Score 1Negligible: Pathogen survival and mode of transmission of the disease are not influenced by increased rainfallScore 2Low: pathogen survival and mode of transmission of the disease are slightly influenced by increased rainfallScore 3Moderate: pathogen survival and mode of transmission of the disease are moderately influenced by increased rainfallScore 4High: pathogen survival and mode of transmission of the disease are highly influenced by increased rainfallE2Influence of annual [humidity]{.ul} in the survival and transmission of the pathogen/diseaseScore 0Score 1Negligible: Pathogen survival and mode of transmission of the disease are not influenced by increased humidityScore 2Low: pathogen survival and mode of transmission of the disease are slightly influenced by increased humidityScore 3Moderate: pathogen survival and mode of transmission of the disease are moderately influenced by increased humidityScore 4High: pathogen survival and mode of transmission of the disease are highly influenced by increased humidityE3Influence of annual [temperature]{.ul} in the survival and transmission of the pathogen/diseaseScore 0Score 1Negligible: Pathogen survival and mode of transmission of the disease are not influenced by increased temperatureScore 2Low: pathogen survival and mode of transmission of the disease are slightly influenced by increased temperatureScore 3Moderate: pathogen survival and mode of transmission of the disease are moderately influenced by increased temperatureScore 4High: pathogen survival and mode of transmission of the disease are highly influenced by increased temperature

Number of Criteria = 3, hence 30 points to be distributed within this domain for the intra‐domain weighing.

**DOMAIN F. WILDLIFE INTERFACE**F1Potential roles of zoo\'s in the (re)emergence of the pathogenScore 0Score 1Negligible: The disease can be present in zoo animals but it is not known to have been transmitted from zoo animals to livestock.Score 2Low: The disease can enter a zoo (e.g. with introduction of an infected exotic animal) but only accidental transmissions of the disease from zoo animals to livestock have been reported. Hence, zoos have a low effect on the (re)emergence of the disease in Belgium\'s livestockScore 3Moderate: The disease can enter a zoo and be present in zoo animals but it needs a vector (biological/mechanical) for its transmission into livestock. Therefore, zoos have a moderate effect on the (re)emergence of the disease in Belgium.Score 4High: Disease can be introduced to a zoo via an infected imported animal, zoo animals can carry the disease that can easily jump to livestock animalsF2The rural(farm)‐wildlife interfaceScore 0Score 1Negligible: The disease has never (re)emerged from the narrowing of the farm‐wild interfaceScore 2Low: The disease has a low probability to (re)emerge via the livestock farm‐forest interface. The disease has been known to (re)emerge from the wild bush but very rarelyScore 3Moderate: The disease has a moderate probability of (re)emergence via the farm/wildlife interface. Barriers ( natural or artificial) are needed to keep the disease/pathogen (re)emerging in livestockScore 4High: there is a high probability for the disease to (re)emerge via the farm/forest interface. Barriers (natural or artificial) separating farms from natural forests are ineffectiveF3Increase of autochthons (indigenous animal) wild mammals in Belgium and neighbouring countriesScore 0Null: Disease has not been reported in wildlifeScore 1Negligible: The increase the autochthonous mammals population does not affect the risk of the diseases to (re)emergenceScore 2Low: The slight increase of autochthonous mammals can slightly increase the probably of the disease emergingScore 3Moderate: The increase of wild mammals has been associated with the re‐emergence of the diseaseScore 4High: The increase of wild mammals [IS the only factor]{.ul} associated with outbreaks of the disease in livestockF4Increase in endemic/migrating populations of wild birds.Score 0Null: Wild/migrating birds are not a reservoir of the diseaseScore 1Negligible: there is a negligible probability of disease (re)emerging in livestock because of an increase in populations of endemic/migrating wild birds.Score 2Low: there is a low probability of the disease (re)emerging and spreading through increased populations of endemic/migrating wild birds. Disease has spread from the endemic/migrating wild birds but only accidentally or under exceptional circumstancesScore 3Moderate: there is a moderate probability of disease being introduced and spread through increased populations of endemic/migrating wild birds. They are hosts and in close contact with domestic livestock (i.e. poultry farms) may spread the diseaseScore 4High: there is a high probability for a disease to (re)emerge through increased populations of wild/migrating birds. These are hosts or reservoirs of the diseaseF5Hunting Activities: hunted animals can be brought back to where livestock is presentScore 0Score 1Negligible: The risk of the disease/pathogen of (re)emerging in livestock due to hunting activities is practically nullScore 2Low: Disease is present in hunted wildlife and birds and only accidental cases have been reported in livestock that have (re)emerged because of hunting. The risk of the disease/pathogen of (re)emerging in livestock due to hunting activities is practically nullScore 3Moderate: Disease is present in hunted wildlife and birds but a certain control is established by the hunterScore 4High: Disease is present in hunted wildlife and birds and hunting is one of the main modes of transmission of the disease to livestockF6Transboundary movements of terrestrial wildlife from other countriesScore 0Null: Disease is not carried by terrestrial wildlifeScore 1Negligible: (re)emergence of the disease by terrestrial movements of wildlife has only been suspected but never confirmed.Score 2Low: There is a low probability for the disease to (re)emerge and spread through transboundary movements of terrestrial wildlifeScore 3Moderate: There is a moderate probability for the disease to (re)emerge and spread through transboundary movements of terrestrial wildlifeScore 4High: There is a high probability for the disease to (re)emerge and spread through transboundary movements of terrestrial wildlife. These are host and may spread/carry the disease along.

Number of Criteria = 6, hence 60 points to be distributed within this domain for the intra‐domain weighing.

**DOMAIN G. HUMAN ACTIVITIES**G1In‐ and out‐people movements linked to tourismScore 0Score 1Negligible: The movement of tourism is a negligible driver on the emergence or re‐emergence of the diseaseScore 2Low: Tourism increase has a low driver of the (re)emergence of the disease.Score 3Moderate: Tourism increase has a moderate driver for the (re)emergence of the disease. Biosecurity measures are enough to stop the entering of the pathogen.Score 4High: Tourist movement is a high driver on the (re)emergence of a disease. Tourists are highly likely to bring the disease into Belgium in their belongings and biosecurity measures are insufficient to stop the pathogenG2Human ImmigrationScore 0Score 1Negligible: The immigration movements are a negligible driver of the disease (re)emergence in BelgiumScore 2Low: The immigration movements are a low driver of the disease (re)emergence in BelgiumScore 3Moderate: The disease is currently present in countries where more immigrants come from and pathogen highly likely to enter through, clothes, shoes and or possession, but the current biosecurity measures in place are able to prevent the emergence of the disease in BelgiumScore 4High: the immigration movement has a high effect as a driver on the emergence or re‐emergence of disease in Belgium. Disease is highly likely to emerge using this route as biosecurity measures are not enough to avoid emergence of the diseaseG3Transport movements: more specifically commercial flights, commercial transport by ships, cars or military (EXCLUDING TRANSPORT VEHICLES OF LIVE ANIMALS).Score 0Score 1Negligible: the role of commercial movements as a driver on the (re)emergence of the disease in Belgium is negligible.Score 2Low: the role of commercial movements as a driver on the (re)emergence of the disease in Belgium is low. It is easily preventable by implementing biosecurity measuresScore 3Moderate: the role of commercial movements as a driver on the (re)emergence of a disease in Belgium is moderate. Disease can be prevented if biosecurity measures are tightened.Score 4High: the role of commercial movements as a driver on the (re)emergence of a disease in Belgium is high. Disease is hard to control via the current biosecurity measures.G4Transport vehicles of live animalsScore 0Score 1Negligible: the role of transport vehicles of live animals as a driver for the (re)emergence of the disease in Belgium is negligibleScore 2Low: the role of transport vehicles of live animals as a driver for the (re)emergence of the disease in Belgium is low.Score 3Moderate: the role of transport vehicles of live animals as a driver for (re)emergence of the disease in Belgium is moderate.Score 4High: the role of transport vehicles of live animals as a driver for (re)emergence of the disease in Belgium is highG5Bioterrorism potentialScore 0Score 1Negligible: the role of bioterrorism as a driver for a disease to (re)emerge is negligible: agent is available but difficult to handle or has a low potential of spread or generates few economic consequencesScore 2Low: the role of bioterrorism as a driver for a disease to (re)emerge is low: agent is available and easy to handle by professionals and labs but has a low spreadScore 3Moderate: the role of bioterrorism as a driver for a disease to (re)emerge is moderate: agent available and easy to handle by professionals and labs and rapidly spreadsScore 4High: the role of bioterrorism as a driver for a disease to (re)emerge is high: Agent is available and easy to handle by individuals and rapidly spreadsG6Inadvertent release of an exotic infectious agent from a containment facility, for example LaboratoryScore 0Score 1Negligible: the pathogen is not currently present in any laboratoryScore 2Low: the pathogen is present in a containment facility but its release is very unlikely as it is very easily containedScore 3Moderate: the pathogen is present in a containment facility and its release can occur as not easily containedScore 4High: pathogen is handled in a risk 3 or 4 laboratory (BSL3 or BSL4) in the country. It can leave the facility if the correct biosecurity measures are not implemented correctly and easily spread to livestock

Number of Criteria = 6, hence 60 points to be distributed within this domain for the intra‐domain weighing.

**DOMAIN H. ECONOMIC AND TRADE ACTIVITIES**H1Decrease of resources allocated to the disease surveillanceScore 0Score 1Negligible: resources allocated to the disease surveillance have no effect on the (re)emergence of the disease in Belgium. Disease has never been under surveillanceScore 2Low: resources allocated to the disease surveillance have a low effect on the (re)emergence of the disease in Belgium. Disease has been under surveillance in the past and no change has happened after surveillance has been stopped.Score 3Medium: resources allocated to the disease surveillance have a moderate effect on the (re)emergence of the disease in Belgium. Disease is under passive surveillance (reported only when observed) but with no need to further increase its surveillanceScore 4High: resources allocated to the disease surveillance have a high effect on the (re)emergence of the disease in Belgium. Disease needs to be under active and passive surveillance as its (re)emergence can easily occur, therefore if its surveillance decreases it\'s highly likely to (re)emergeH2Modification of the disease status (i.e. reportable disease becoming [not]{.ul} reportable) or change in screening frequency due to a reduced national budget.Score 0Score 1Negligible: modification of the disease status due to a reduced national budget has a negligible effect on the (re) emergence of the disease in BelgiumScore 2Low: modification of the disease status due to a reduced national budget has a low effect on the (re) emergence of the disease in BelgiumScore 3Moderate: modification of the disease status due to a reduced national budget has a moderate effect on the (re) emergence of the disease in BelgiumScore 4High: modification of the disease status due to a reduced national budget has a high effect on the (re) emergence of the disease in BelgiumH3Decrease of resources allocated to the implementation of biosecurity measures at border controls (e.g. harbours or airports).Score 0Score 1Negligible: decreasing the resources allocated to the implementation of biosecurity measures has a negligible effect on the (re)emergence of the disease in Belgium. Disease has never been detected in the past in a harbour or airportScore 2Low: decreasing the resources allocated to the implementation of biosecurity measures has a low effect on the (re)emergence of the disease in Belgium. The disease has been suspected to have entered other countries because of deficient biosecurity at border controls.Score 3Medium: decreasing the resources allocated to the implementation of biosecurity measures has a moderate effect on the (re)emergence of the disease in Belgium. The disease has been introduced in other countries because of deficient biosecurity at border controlsScore 4High: decreasing the resources allocated to the implementation of biosecurity measures highly increases the risk of (re)emergence of the disease in Belgium. In the past, the disease has been introduced in other countries [AND]{.ul} in Belgium because of deficient biosecurity at border controlsH4Most likely influence of (il)legal movements of live animals (livestock, pets, horses, etc.) [from neighbouring/European Union member states (MS)]{.ul} for the disease to (re)emerge in Belgium.Score 0Score 1Negligible: (il)legal movements of live animals (livestock, pets, horses, etc.) from neighbouring/European Union MS have a [negligible influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 2Low: (il)legal movements (livestock, pets, horses, etc.) from neighbouring/European Union MS have a [low influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 3Moderate: (il)legal movements (livestock, pets, horses, etc.) from neighbouring/European Union MS have a [moderate influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 4High: (il)legal movements (livestock, pets, horses, etc.) from neighbouring/European Union MS have a [high influence]{.ul} on the pathogen/disease (re)emergence in Belgium.H5Influence of increased (il)legal imports of [animal subproducts]{.ul} such as skin, meat and edible products [from EU member states]{.ul} for the disease/pathogen to (re)emerge in BelgiumScore 0Score 1Negligible: increased (il)legal imports of animal subproducts such as skin, meat and edible products from EU member states have a [negligible influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 2Low: increased (il)legal imports of animal subproducts such as skin, meat and edible products from EU member states have a [low influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 3Moderate: increased (il)legal imports of animal subproducts such as skin, meat and edible products from EU member states have a [moderate influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 4High: increased (il)legal imports of animal subproducts such as skin, meat and edible products from EU member states have a [high influence]{.ul} on the pathogen/disease (re)emergence in Belgium.H6Most likely influence of increased (il)legal imports of NON‐animal products such as tires, wood, furniture [from EU member states]{.ul} for the disease/pathogen to (re)emerge in Belgium.Score 0Score 1Negligible: increased (il)legal imports of NON‐animal products such as tires, wood, furniture from EU member states have a [negligible influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 2Low: increased (il)legal imports of NON‐animal products such as tires, wood, furniture from EU member states have a [low influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 3Moderate: increased (il)legal imports of NON‐animal products such as tires, wood, furniture from EU member states have a [moderate influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 4High: increased (il)legal imports of NON‐animal products such as tires, wood, furniture from EU member states have a [high influence]{.ul} on the pathogen/disease (re)emergence in Belgium.H7Most likely influence of (il)legal movements of li[ve animals]{.ul} (livestock, pets, horses, etc.) from [Third countries]{.ul} for the disease to (re)emerge in Belgium.Score 0Score 1Negligible:(il)legal movements of live animals (livestock, pets, horses, etc.) from Third countries have a [negligible influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 2Low: (il)legal movements of live animals (livestock, pets, horses, etc.) from Third countries have a [low influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 3Moderate: (il)legal movements of live animals (livestock, pets, horses, etc.) from Third countries have a [moderate influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 4High: (il)legal movements of live animals (livestock, pets, horses, etc.) from Third countries have a [high influence]{.ul} on the pathogen/disease (re)emergence in Belgium.H8Most likely influence of increased imports of animal subproducts such as skin, meat and edible products[from Third countries,]{.ul} for the disease to (re)emerge in Belgium.Score 0Score 1Negligible: Increased imports of animal subproducts such as skin, meat and edible products from Third countries have a [negligible influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 2Low: Increased imports of animal subproducts such as skin, meat and edible products from Third countries have a [low influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 3Moderate: Increased imports of animal subproducts such as skin, meat and edible products from Third countries have a [moderate influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 4High: Increased imports of animal subproducts such as skin, meat and edible products from Third countries have a [high influence]{.ul} on the pathogen/disease (re)emergence in Belgium.H9Most likely influence of increased (il)legal imports of NON‐animal products such as tires, wood, furniture [from Third countries,]{.ul} for the disease to (re)emerge in Belgium.Score 0Score 1Negligible: increased (il)legal imports of NON‐animal products such as tires, wood, furniture from Third countries have a [negligible influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 2Low: increased (il)legal imports of NON‐animal products such as tires, wood, furniture from Third countries have a [low influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 3Moderate: increased (il)legal imports of NON‐animal products such as tires, wood, furniture from Third countries have a [moderate influence]{.ul} on the pathogen/disease (re)emergence in Belgium.Score 4High: increased (il)legal imports of NON‐animal products such as tires, wood, furniture from Third countries have a [high influence]{.ul} on the pathogen/disease (re)emergence in Belgium.

Number of Criteria = 9, hence 90 points to be distributed within this domain for the intra‐domain weighing.

List of experts enrolled (*N* = 14) in the phase I (questionnaire assessment) with their gender, affiliation, country and field of expertise {#tbed13356-sec-0023}
============================================================================================================================================

ExpertGenderInstitutionBackgroundCountryField of expertiseKeywordsKris de ClercqMSciensanoDVM, MSc, PhD, Head of Unit, SciensanoBelgiumExotic viruses and transmissible spongiform encephalopathiesExotic diseasesPhilippe LeonardMUniversity Hospital CenterMedical doctorBelgiumInfectious diseasesTravel medicineDirk BerkvensMUniversityIr, PhD, Institute of Tropical Medicine, AntwerpBelgiumEpidemiology and quantitative risk analysisVeterinary epidemiologyEtienne ThiryMUniversityDVM, PhD, Dipl. ECVPH, Professor, Liege UniversityBelgiumVirology and viral diseasesVeterinary virologyNathalie KirschvinkFUniversityDVM, PhD. Professor, University of NamurBelgiumAnimal physiologyArbovirusesThierry van den BergMSciensanoDVM, MSc, PhD, Operational Director Viral diseases at SciensanoBelgiumViral diseases, Avian influenza, Newcastle, SchmallenbergAvian viruses, viral diseasesChristian Gortazar SchmidtMUniversityDVM, PhD, Professor at the University of Castilla‐La Mancha, Spain. Head of SaBio (Sanidad y Biotechnologia) of IRECSpainDiseases and ecology of wild faunaPopulation dynamics, Epidemiology, Ecology, animal healthHendriks PascalMAnsesDVM, PhD, Scientific director of epidemiology and surveillanceFranceAnimal health, surveillance, veterinary epidemiologySurveillance systemsFabiana Dal PozzoFAMCRADVM, MSc, PhD, Scientific Coordinator at AMCRABelgiumViral diseases, Bluetongue, laboratory diagnostics, Q feverViral diseases, arboviruses, Antibiotic resistanceMorgane DominguezFOIEDMV, PhD, OIE project officerFranceEpidemiology, Risk analysis in veterinary sciencesVeterinary epidemiology, biosecurityBoelaert FrankMEFSADVM, MSc, PhD, Dipl. ECVPH, Senior Scientific Office at the Biological hazards and contaminants Unit of EFSAItalyZoonoses, public health, surveillance of zoonoses and food‐borne outbreaksSurveillance, EU surveillanceVanholme LucMFASFCDVM, Federal agency for the Safety of the Food Chain, General Direction of Control policyBelgiumVeterinary medicine, Animal diseases, Control policyAnimal diseasesLaetitia LempereurFUniversityDVM, PhD, Dipl. EVPC, Assistant Professor of parasitology, Liege UniversityBelgiumParasitology, Vector‐borne diseasesTick‐borne animal diseasesDepoorter PieterMFASFCDMV, Federal Agency for the Safety of the Food Chain, General Direction of Control Policy, Risk DirectionBelgiumVeterinary medicine, Animal diseases, Control policyAnimal diseases

List of experts enrolled (*N* = 62) in phase II (disease prioritization) with their gender, affiliation, country, field of expertise and disease they answered for {#tbed13356-sec-0024}
==================================================================================================================================================================

ExpertGenderInstitutionBackgroundCountryField of expertiseKeywordsDisease expert answeredAgnes WaretFUniversityDVM, MSc, PhD, Assistant Lecturer, Swine production and pathology, University of Toulouse, FranceFranceEpidemiology of animal infectious diseases in southern countries, animal health economyAnimal healthPeste des petits RuminantsAlexandre CaronMCIRADDVM, PhD, CIRAD‐UPR AGIRsFranceDisease ecology at the wildlife/domestic interface in border conservation areas, thinking sustainable and resilient socio‐ecosystems in borders of conservation areasDisease ecologyPeste des petits RuminantsAna Alba CasalsFCReSADVM, PhD, Epidemiology Unit, CReSASpainData Mining and knowledge discoveryWest Nile FeverWest Nile FeverAna de la GrandièreFUniversityDMV, PhD, Department of infectious and parasitic diseases, Liege UniversityPortugalVirology and viral diseasesAfrican horse sicknessAfrican horse sicknessAna Sofia RamirezFUniversityDMV, MSC, Heidelberg University, GermanyGermanyInfectious Diseases, Epidemiology, Ventilation, Tuberculosis, Airway obstructionInfectious diseasesContagious Bovine Pleuropneumonia Contagious Caprine pleuropneumoniaAndrea ApolloniMCIRADM.A., Physics, PhD, Researcher at CIRADFranceModelling of infectious diseasesComputational epidemiologyContagious Bovine Pleuropneumonia Contagious Caprine pleuropneumoniaAnette BotnerFDTU VETDMV, PhD, Division of Diagnostics & Scientific Advice ‐ Virology, National Veterinary InstituteDenmarkVeterinary virologyViral diseasesPorcine Epidemic DiarrhoeaAnn Brigitte CayFSciensanoBio Engineer, PhD, Head of Unit Enzootic and Re‐emerging viral diseases, SciensanoBelgiumMolecular Biology, Molecular Cloning, Cell Biology, InfectionHorse diseasesWest Nile feverAnnelise TranFCIRADPhD, Animal et Gestion Intégrée des Risques (AGIRS), CIRADFranceSpatial Analysis, Remote Sensing, Geographic Information System, Environmental scienceArbovirusesRift Valley feverAxel MauroyMUniversityDVM, PhD, Assistant Professor of Veterinary Virology at the University of LiegeBelgiumVirology, Viral diseasesArbovirusesAino, akabane, Low pathogenic avian influenza, High pathogenic avian influenza, Porcine epidemic diarrhoea, Schmallenberg, Vesicular stomatitisBart PardonMGhent University, AssistantDVM, PhD, Dip ECBHM, Ghent University, Doctor Assistant of internal medicine of large animals at Ghent University.BelgiumInternal Medicine, Infectious DiseasesRespiratory Diseases, Internal Medicine, Infectious DiseasesHaemorrhagic SepticaemiaBénédicte LambrechtMSciensanoDVM, PhD, Head of Scientific Service Avian virology and immunology, SciensanoBelgiumAvian virology and immunologyNewcastle diseaseNewcastle diseaseBenoît DurandMANSESDVM, MSc, PhD, Epidemiology unit, ANSESFranceEpidemiology unitAnimal diseases, modellingWestern Equine Encephalitis, Eastern Equine Encephalitis, Venezuelan Equine Encephalitis, Foot‐and‐mouth diseaseBenoit MuylkensMUniversityDVM, PhD, Professor at the University of NamurBelgiumVirology (herpes virus, vaccination) control of viral genetics expressionArbovirusesAkabaneCecile BeckFANSESDVM, PhD, Laboratory of animal health, ANSESFranceVirologyAntibodies, ELISA, Virus, VaccinationVenezuelan equine encephalitisChris OuraMUniversityDVM, PhD, Senior lecturer in Veterinary Virology, University of the West Indies, Trinidad and TobagoTrinidad and TobagoVirology, One‐Health, Zoonotic and animal pathogens, Emerging infectious diseasesExotic diseasesAfrican Swine feverChristelle FabletFANSESDEA, Biology and production animals, PhD, Epidemiologist at ANSESFranceEpidemiologist, Animal Productions, Respiratory Diseases, SwineEpidemiology, One health initiative.Novel swine enteric coronavirusDirk BerkvensMUniversityIg., MSc, PhD, Institute of Tropical Medicine, AntwerpBelgiumEpidemiology and quantitative risk analysisEpidemiology, modellingBluetongue, Rift Valley feverDucatez MarietteFUniversityDVM, PhD, Host‐pathogen interaction, University of ToulouseFrancePCR, Genotyping, Emerging Infectious Diseases, Viral infectionInfluenza virusesLow pathogenic avian influenza, High pathogenic avian influenzaEthienne ThiryMUniversityDVM, PhD, University Professor, Unit of Virology and Viral Diseases, University of LiègeBelgiumVirologyVirus, Animal, emerging diseases, geneticsAino, Akabane, Vesicular stomatitisEmmanuel BreadMANSESDMV, PhD, Laboratory for Animal Health, ANSESFrancePCR, Cell culture, Infection, Immunology of infectious diseasesArbovirusesBluetongue, Epizootic haemorrhagic disease, SchmallenbergFabiana Dal PozzoFAMCRADVM, MSc, PhD, Scientific Coordinator at AMCRABelgiumViral diseases, bacterial diseasesViral diseases, poxviruses, arboviruses, antibiotics resistanceAfrican horse sickness, Bluetongue, Epizootic haemorrhagic diseases, Sheep and goat poxFrancois RogerMCIRADDVM, MSc, PhD, Animals, Health, Territories, Risks and Ecosystems Unit, CIRADFranceEpidemiology, Infectious diseases, BiostatisticsOne Health*Peste des petits Ruminant*Francois ThiaucourtMCIRADDVM, PhD, Researcher at CIRADFranceAnimal Science, Cattle, Vaccine DevelopmentAnimal Science, Cattle, Diagnostics, Molecular Biological TechniquesContagious Bovine Pleuropneumonia, Contagious Caprine pleuropneumoniaFrank KoenenMSciensanoDVM, PhD, One Health Unit, SciensanoBelgiumSurveillance, Swine diseasesClassical Swine Fever, African Swine FeverAfrican Swine Fever, Classical swine feverGaby Van GalenFUniversityDVM, MSc, PhD, DES, Dipl. ECEIM, Dipl ECVECC, Associate Professor, University of SidneyAustraliaEquine medicineInternal Medicine and SurgeryAfrican horse sickness, Eastern equine encephalitis, Western equine encephalitis, Japanese encephalitisGilles MeyerMUniversityDMV, PhD, ECBHM, University of Toulouse, ProfessorFranceVeterinary Virology, Viral, Ruminant PathologyVeterinary virology, vector‐borne diseasesAino, SchmallenbergGrasland BeatriceFANSESPhD, ANSESFranceSwine virology and diseasesVirology, Nomenclature, Swine Diseases, PRRSNovel swine enteric coronavirusGuy CzaplickiMARSIADVM, MSc, Head of a veterinary diagnostic laboratoryBelgiumLaboratory diagnosisAnimal serology, bovine pathology, swine pathology, epidemiology, animal infectiologyFoot‐and‐mouth disease, swine vesicular diseases, vesicular stomatitisGuy‐Pierre MartineauMUniversityDVM, PhD, Diplomate of ECPHM, Professor at the National Veterinary School of ToulouseFranceMedicine and porcine productionPig productionNovel swine enteric coronavirus, Swine vesicular diseaseIgnacio Garcia BocanegraMUniversityDVM, PhD, Dip. ECZM, Professor of animal Health at the University of Cordoba, SpainSpainAnimal health, wildlife population healthWildlife population healthWest Nile FeverJames WoodMUniversityDVM, MSc, PhD, Dipl. ECVPH, Professor, Department of Veterinary Medicine, University of CambridgeUnited KingdomEpidemiology, infection dynamic, control of diseases in Africa and globallyHorse diseases, Bat ecologyAfrican horse Sickness, Nipah virusJaques MainilMUniversityDVM, PhD, Professor, Bacteriology and Bacteriologic Diseases, University of LiègeBelgiumBacteriologyBacteriology, pathogeny, genetics (prokaryotes), molecular epidemiology, plasmidologyHaemorrhagic SepticaemiaJean GuillotinMDepartmental laboratoryDMV, Departmental laboratoryFranceDiagnosis of animal diseasesSwine diseasesClassical swine feverJean Pierre GanièreMUniversityDMV, PhD, OnirisFranceMandatory diseasesAnimal diseasesPeste des petits RuminantsJean‐Pierre VaillancourtMUniversityDVM, MSc, PhD, Professor titulaire, University of MontrealCanadaEpidemiology of zoonosis and public health, Infectious diseases of swine and poultryPublic health, biosecurityNewcastle diseaseJordi CasalMUniversityDVM, University Professor, Universidad Autonoma de BarcelonaSpainAnimal HealthAnimal epidemiology, zoonoses, biosecurityFoot‐and‐mouth disease, lumpy skin disease, Rift valley fever, vesicular stomatitisJoseph HooyberghsMFASFCDVM, MSc, Federal agency for the safety of the food chain, General Direction of Control PolicyBelgiumAnimal diseases, virologyEpidemic diseasesAfrican swine fever, classical swine fever, porcine epidemic diarrhoeaJulien CappelleMCIRADDVM, PhD, Health Ecologist, CIRADFranceWildlife ecologyEcology, epidemiology, WildlifeNipah virusKris De ClercqMSciensanoDVM, MSc, EU Reference Laboratory for FMD viruses, SciensanoBelgiumExotic viruses and transmissible spongiform encephalopathiesExotic diseasesFoot‐and‐mouth disease, lumpy skin disease, sheep and goat poxLabib Bakkali KassimiMANSESDVM, PhD, Head of FAO reference centre and OIE reference laboratory for FMD at ANSESFranceVirology, immunology, molecular biologyLaboratory, Foot‐and‐mouth diseaseFoot‐and‐mouth diseaseLecoq LaurelineFUniversityDVM, DES, MSc, Dipl. ACVIMBelgiumEquine medicineHorse diseasesJapanese encephalitisLouis LignereuxMUniversityDMV, MSc, Liege UniversityAustraliaManagement of wildlife diseases, Animal diseasesAnimal diseasesContagious caprine PleuropneumoniaLudovic MartinelleMUniversityDVM, MSc, PhD, Head of the Experimental Station (CARE‐FePex) at Liege UniversityBelgiumEpidemiology, pathogenesis of Bluetongue and ShmallenbergPathogenesis, Bluetongue, SchmallenbergAino, Akabane, Epizootic haemorrhagic diseaseMarie‐France HumbletFUniversityDVM, MSC, PhD, Department of Occupational Protection and Hygiene, Biosafety and Biosecurity section, Liege UniversityBelgiumBiosecurity, epidemiologyBiosecurity, Hygiene, EpidemiologyJapanese encephalitis, Newcastle disease, Venezuelan equine encephalitis, West Nile feverMarilena FilippitziFSciensanoDVM, PhD, Dipl. ECVPH, Veterinary epidemiology, SciensanoBelgiumVeterinary epidemiology, Risk assessment, Antimicrobial resistance, BiosecurityDisease surveillance, Antimicrobial resistanceRift Valley feverMarius GilbertMUniversityApplied Biological Sciences, PhD, Head of spatial epidemiology Lab, FNRS Research Associate at the Universite Libre de Bruxelles.BelgiumSpatial epidemiology of animal diseasesEcology, population biology,Low pathogenic avian influenza, High pathogenic avian influenzaMarylene TignonFSciensanoLic., MSc, PhD, Virology Department, SciensanoBelgiumVeterinary virology, Porcine, bovine and horse viral diseasesDiagnosisAfrican horse sicknessMutien‐Marie GariglianyMUniversityDVM, PhD, Dipl. ECVP, General pathology, Liege UniversityBelgiumPathologist of infectious disease, avian influenzaInfluenza, PathologyBluetongue, Epizootic haemorrhagic disease, SchmallenbergNick De ReggeMSciensanoDMV, PhD, Virology Department, SciensanoBelgiumInfectious animal diseases, Enzootic and vector‐borne diseases.Vector‐borne diseases, Arthropod vectorsWestern Equine Encephalitis, Eastern Equine Encephalitis, Venezuelan Equine Encephalitis, Swine vesicular diseases, vesicular stomatitisNicolas RoseMANSESDVM, PhD, Swine Epidemiology and Welfare Unit, ANSESFranceSwine epidemiologyEpidemiology, Animal welfareAfrican swine fever, Classical swine fever, Novel swine enteric coronavirus, Porcine epidemic diarrhoeaPatrick ButayeMUniversityDVM, PhD, School of Veterinary Medicine, Ross UniversityBelgiumMicrobiologyMicrobiology, Antimicrobial resistanceHaemorrhagic septicaemiaPaul KitchingMThe Pirbright InstituteDMV, PhD, The Pirbright InstituteUnited KingdomVirologyPoxvirusesLumpy skin disease, sheep and goat poxPhilippe CaufourMCIRADDVM, PhD, Department BIOS, CIRADFranceVirology, Immune responsePoxvirusesLumpy skin disease, sheep and goat poxRuben RosalesMUniversityDMV, PhD, Universidad de Las Palmas de Gran CanariaSpainVeterinary science, Veterinary diagnostics, Veterinary infectious diseases, Veterinary epidemiologyInfectious diseasesContagious Bovine Pleuropneumonia, Contagious Caprine pleuropneumoniaStephan ZientaraMAnsesDVM, MSc, PhD, Head of Virology and of the National Reference Laboratory for Foot‐and‐Mouth Disease, Bluetongue, West Nile and African Horse SicknessFranceVirologyFoot‐and mouth disease, Bluetongue West Nile Fever, Equine viral diseasesBluetongue, Epizootic haemorrhagic diseaseSteven Van GutchMSciensanoDVM, MSC, PhD, Head of Viral Diseases, SciensanoBelgiumVirologyBat diseasesNipah virusSylvie LecollinetFANSESDVM, PhD, Laboratory for Animal health, ANSESFrancePCR, Infection, ELISA, Viral InfectionViruses, Equine MedicineWestern equine encephalitis, Eastern equine encephalitis, Japanese encephalitis, Venezuelan equine encephalitis, West Nile feverThierry van den BergMSciensanoDMV, PhD, MSc, Operational Director Viral diseases at SciensanoBelgiumViral diseases, Avian influenza, NewcastleAvian viruses, viral diseaseLow pathogenic avian influenza, High pathogenic avian influenza, NewcastleThomas HagennartsMUniversityDMV, PhD, Bacteriology and Epidemiology, University of WageningenThe NetherlandsBiology, Ecology, Epidemiology, Mathematics, Veterinary scienceSwine diseasesSwine vesicular diseasePierre WattiauMSciensanoBachelor Degree in Industrial Chemistry, MSc, PhD, Veterinary bacteriology Department, SciensanoBelgiumLaboratory techniques, Bacterial isolation and identification, Antibiotic susceptibility testing, Molecular detectionLaboratory MicrobiologyHaemorrhagic septicaemiaWeerapong ThanapongtharmMMinistryDVM, PhD, Senior Veterinary Office at Ministry of Agriculture and Cooperatives, ThailandThailandAnimal Health, livestock developmentSpatial analysisNipah virus
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Means, Standard deviation, Median and Range of the scores of the diseases. Ranking of the diseases according to the mean score and to the median score are also shown

  Disease                                   Mean (*SD* [a](#tbed13356-note-0008){ref-type="fn"})   Rank   Median      Rank   Range[d](#tbed13356-note-0011){ref-type="fn"}
  ----------------------------------------- ------------------------------------------------------ ------ ----------- ------ -----------------------------------------------
  Porcine epidemic diarrhoea                4,143.38 (469.88)                                      1      4,090       2      1,111
  Foot and mouth disease                    4,057.36 (546.83)                                      2      4,053.75    3      1,428.75
  Low pathogenic avian influenza            3,974.13 (376.09)                                      3      4,114.5     1      830
  African horse sickness                    3,974.1 (527.52)                                       4      3,940.75    4      1,411
  Highly pathogenic avian influenza         3,804.5 (327.9)                                        5      3,787.375   7      616.75
  Contagious bovine pleuropneumonia         3,789.35 (1,297.83)                                    6      3,164       25     2,640.6
  Sheep and goat pox                        3,765.06(434.19)                                       7      3,702.125   10     972
  Classical swine fever                     3,745.33 (117.13)                                      8      3,758.15    8      275
  Lumpy skin disease                        3,691.29 (488.16)                                      9      3,586.75    13     1,135.85
  Venezuelan equine encephalitis            3,625.75 (671.92)                                      10     3,853.75    5      1,441.25
  Contagious caprine pleuropneumonia        3,617.45 (1,099.65)                                    11     3,247.25    21     2,681.75
  Epizootic haemorrhagic disease            3,599.63 (532.13)                                      12     3,723.75    9      1,165.65
  Novel swine enteric coronavirus disease   3,586 (322.33)                                         13     3,542.125   14     760.25
  Bluetongue                                3,499.22 (652.21)                                      14     3,837.5     6      1,465
  Western equine encephalitis               3,491.81 (647.42)                                      15     3,591.875   12     1,411
  African swine fever                       3,479.96 (411.22)                                      16     3,464.375   16     872.6
  Eastern equine encephalitis               3,479.38 (590.71)                                      17     3,608.125   11     1,248.75
  Schmallenberg                             3,459.19 (113.93)                                      18     3,442.125   17     267.5
  Vesicular stomatitis                      3,450.4 (1,043.85)                                     19     3,011.25    26     2,574.25
  Akabane disease                           3,444.55 (814.42)                                      20     3,437.6     18     1,623
  Swine vesicular disease                   3,425.25 (512.82)                                      21     3,333       19     1,195
  Aino disease                              3,424.75 (455.24)                                      22     3,330.375   20     996.75
  NewCastle                                 3,312.75 (770.34)                                      23     3,504       15     1,783
  Rift valley fever                         3,303.6 (433.98)                                       24     3,192       24     1,011.6
  Haemorrhagic septicaemia                  3,193.44 (218.2)                                       25     3,230       22     513.75
  Japanese encephalitis                     3,169.56 (763.67)                                      26     3,005       27     1,811.75
  West Nile fever                           3,146.47 (419.96)                                      27     3,206.25    23     1,132.5
  Peste des Petits Ruminants                2,989.31 (698.7)                                       28     2,841.25    29     1,602.75
  Nipah virus                               2,936.56 (1,038.14)                                    29     2,937.125   28     2,369

*SD* = Standard Deviation.

Rank Mean = The ranking of the disease obtained with the mean scores.

Rank Median = The ranking of the disease obtained with the median.

Range = The range of the scores obtained from the expert\'s scores.
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